Back 

Archive 2007 Prescription Drug State Legislation

 

2007 Prescription Drug State Legislation

Updated June 17, 2008 - Subject to additions and regular updates during session months.

     Introduction    |   Rx Summary - Table 1   |  Rx Bills by State - Table 2   |   Rx Resources
 
 NEW: "2008 Prescription Drug State Legislation" - continues this 2007 report, with newly filed bills and actions specific to 2008.  Updated frequently


The total U.S. spending on pharmaceuticals is projected to top $229 billion in 2007, while more than 40 percent of Americans take one or more prescription medications in a year.  These facts help explain why, in 2007, prescription drug policies continue to attract widespread attention and action in state capitols.  [1] 

More than 500 pharmaceutical bills and resolutions were filed for consideration in 2007 legislative sessions.  Two recent nationwide factors are affecting legislative directions this year.  First, the federal Medicare prescription drug benefit now is in its second year, with more stability and fewer problems than last year.  Second, a federal report released in February brought welcome news that the annual increase in pharmaceutical spending had dropped from double-digits three years ago to just 5.8 percent in 2006. That same report credited state and private sector actions with contributing to this economic change. 

Proposed policies cover a wide range of state-sponsored approaches, from creation of subsidies or discount programs, to promoting safer pharmaceuticals and regulating the management, marketing and distribution of prescription products.
 

Map of 2007 Rx legislation

The following are examples of widespread or "hot" topics in 2007:

Expanding Access: Discount and Subsidy Programs -- A majority of states have established subsidy or discount programs to reduce prescription drug costs and provide direct relief to qualified low-income residents.  In 2006, many states retooled their discount and subsidy programs to include Medicare Part D provisions; in 2007 proposed expansions and changes again are on the table in more than 20 states. 

Picture- Rx pills in bottle

Marketing and Advertising -- A few states already require pharmaceutical manufacturers to disclose marketing expenses, including gifts to drug prescribers.  During 2007, at least 27 states propose legislation requiring marketing disclosures by drug manufacturers, regulating direct-to-consumer advertising of prescription drugs by pharmaceutical companies or prohibiting prescription information from being sold for commercial purposes. 

Privacy and "Data Mining" - In 2006 New Hampshire became the first state to prohibit the sale or redistribution of prescription sales record information that identified patients or prescribers.  In 2007, at least 13 states have similar proposals, with laws signed in Maine and Vermont.

Medicare Part D Wrap Around Benefits and Services -- Although federal Medicare pharmaceutical plans appear more stable this year, 20+ states are considering bills and resolutions intended to modify or adjust state pharmaceutical assistance efforts, in response to the federal Medicare Prescription Drug benefit launched in January 2006.  Most bills reference the Medicare Modernization Act or "MMA." Pharmacy Benefit Managers (PBMs) -- At least 23 states have proposed legislation to regulate Pharmacy Benefit Management companies -- the middlemen who negotiate directly with manufacturers.  The bills seek to assure financial reliability, regulate the licensing of pharmacy benefit managers and/or mandate full disclosure of drug costs and financial contracts.  

Prescription Drug Reuse/Recycling -- Allowing or encouraging donation of unused pharmaceutical drugs is a popular idea - nine states passed such laws in 2006. For 2007 interest continues in 10 states, with some of the focus on cancer drug repository programs that allow an individual, health care facility or drug manufacturer to donate cancer drugs or supplies needed to administer cancer drugs for use by those who meet eligibility criteria. 

Electronic Monitoring and Internet Prescribing -- This is a relatively recent trend which gained momentum during the past three years. Proposed laws would allow for the development and regulation of electronic transmission of prescription drug orders, as well as establishing Internet prescribing practices to provide increased protection for consumers purchasing prescription drugs over the Internet.  Additionally, several more states seek to establish electronic prescription drug databases to monitor the misuse, abuse and diversion of prescription drugs and controlled substances. In August Alaska became the final state to change laws and regulations to allow for e-prescribing.


 

Other Topics of Interest -- Several states propose legislation to create bulk prescription drug purchasing or multi-state purchasing programs; others are considering bills to create prescription drug importation or re-importation programs.  Bills providing for income tax deductions, incentives or credits for pharmaceuticals or prescription drug-related programs were proposed in some states. Cost containment also continues as a focus in some states, using measures to establish or modify preferred drug lists and seek manufacturer rebates or discounts.  Other ideas, such as regulation of mail order prescription drug sales, oversight of pharmaceutical wholesalers, local pharmacy audits and publicizing clinical trials also are possible trends during 2007. 

NCSL's separate 2006 Prescription Drug State Legislation online report includes all bills filed in 2006, including more than 90 resolutions and bills that became law in 30+ states. 

 

2007 Laws and Enacted Resolutions:  So far this year, laws have been passed and signed in these 43 statesAlabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Dakota, Oklahoma, Oregon, South Dakota, Phode Island, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.    In addition, the District of Columbia passed a 2007 bill in January 2008.
Non-binding resolutions have been adopted in Hawaii, Idaho, Kentucky and Texas

This tracking report is designed to be updated regularly; future editions will include additional bills filed during the session year.  The report generally does not include legislation regulating only pharmacists and pharmacies, nor measures solely affecting existing Medicaid plans.  Topic codes listed for individual bills identify major topics, but may not include all provisions.  Topic codes may include measures that would restrict, as well as expand, use of a particular policy.

Go to an individual state:
AL | AK | AZ | AR | CA | CO | CT | DE | FL | GA | HI | ID | IL | IN | IA | KS | KY | LA | ME | MD | MA | MI | MN | MS | MO | MTNE | NH | NV | NJ | NM | NY | NC | ND | OH | OK | OR | PA | RI | SC | SD | TN | TX | UT | VT | VA | WA | WV | WI | WY |

 

TABLE 1: 2007 Rx Legislation Topic Summary

Prescription Drug Bill Major Topics

Topic Code

States with 2007 legislation  [Subject to additions]
(Bold = passed by legislature; underline = law)

Use of federal 340B discount price program

340B

AK, AR, CT, HI, KS, MA, NH, VT, WV

Access to brand name pharmaceutical products

Brand

FL, GA, ID, KY, LA, MI, MS, NY, PA, RITN, TX, UT, WA, WI

Multi-state or inter-agency bulk purchasing

Bulk

CO, CT, FL, HI, IN, MA, MI, MS, NH, NJ, NY, UT, VT, WV

Clearinghouse information

CL

CO, CT, HI, IL, LA, OK, TX

Discount program

D

CA, CO, HI, IL, IA, (MD), MA, MI, MN, NE, NV, NH, NJ, NY, OK, (OR). PA, RI, TN, TX, VA, WV, WI
Electronically transmitted prescription drug orders and electronic prescribing practices, including electronic monitoring E AL, AK, AZ, AR, CO, CT, FL, GA, IL, KY, LA, ME, MA, MN, MO, MT, NH, NJ, NY, OR, PA, SC, SD, TN, UT, VT, WA, WV

Generic drug use

Generic

CO, CT, FL, GA, LA, MA, MI, MS, NE, NJ, NM, NY, PA, RI, TN, VT

Regulate drug importation or reimportation

Imp

HI, KY, MA, MS, NY, OK, TN
Regulate Internet pharmacies (also see "Electronic" above) Internet AR, IL, LA, MA, NY, SC, TX, UT
 

Regulate forms, labels or packaging on retail Rx, including legibility

Label

AZ, CA, FL, GA, HI, IL, ME, MA,MI, NV, NY, OK, OR, SC, TN, TX, VA

Protect Rx manufacturers or providers from lawsuits

Liability

HI, MI, NY

Mail-order pharmaceuticals (also see PBM)

Mail

ID, MA, NH, NY, RI, SC, TN, TX, VT

Marketing & advertising
(see www.ncsl.org/programs/health/rxads.htm for more information)

Mkt

AZ, CA, CT, FL, GA, HI, ID, IL, KS, ME, MD, MA, MS, MT, NE, NV, NH, NY, OH, OK, OR, RI, TN, TX, VT, WA, WV, WI

Medicaid (partial list; see notes)

M

AZ, CO, CT, FL, GA, HI, ID, IL, IN, IA, KS, LA, ME, MD, MA, MI, MN, MS, NE, NY, OK, OR, RI, TN, TX, UT, VTWA, WV

Medicare Prescription Drug Act (MMA) state changes

MMA

AK, AZ, CA, CT, DE, FL, HI, ID, IL, KY, ME, MD, MA, MN, NJ, NY, OK, RI, TX, VA, WA, WV, WI

Regulation of pharmaceutical benefit managers

PBM

AR, CT, DE, GA, IL, IN, IA, KS, KY, ME, MD, MI, MN, MS, MO, NH, NY, ND, OK, SC, TN, TX, VT, VA, WA, WV

Preferred Drug List

PDL

CO, CT, DE, GA, HI, IN, LA, ME, MA, MN, MO, MS, NY, OK, OR, TN, TX, UT, VT, WV

Relates to pricing of pharmaceuticals

Price

AK, AR, CO, CT, FL, GA, HI, IL, IN, IA, KY, ME, MD, MA, MI, MN, MS, MO, NE, NH, NJ, NM, NV, NY, ND, RI, TX, VT, VA, WV, WI

Restricting sale or disclosure of Rx sales with patient or prescriber info. Privacy AZ, CA, (ID), IL, KS, (KY), ME, MD, MA, NV, NC, RI, TN, TX, VT, WA, WV 

Reuse or recycling of pharmaceuticals

Reuse

AL, CO, IL, ME, MA, MN, MS, NM, NY, ND, OK, PA, RI, SC, TX, WI

State Rx Subsidy program

S

AK, AZ, CA, CT, DE, HI, IL, IN, ME, MD, MA, MN, NH, NJ, NY, PA, RI, VA, WA, WI

Study or task force on Rx

Study

AL, AR, AK, FL, IN, MD, NH, NY, OK, PA,

Income tax deductions, modifications, incentives or credits for pharmaceuticals or prescription drug-related programs Tax IL, LA, MD, MA, NY, VA, WA, WI
Disclose or regulate in-state Rx clinical trials Trials

CA, HI, MS, NJ, NY, PA, RI

Regulate Rx wholesalers; preventing counterfeits Whole AL, AR, CO, GA, ID, IL, IA, KS, KY, MD, MA, MO, (MT), NV, NY, ND, OK, SD, TN, TX, UT, WA, WV, WIWY

Other Rx policy

-

AL, AZ, AR, CA, CT, FL, HI, IL, ME, MD, MA, MSMT, NE, NH, NM, NY, ND, PA, RI, SD, TX, WA

TABLE 2: 2007 Rx Legislation by State

Bills detailed in this table are subject to consideration during 2007 state legislative sessions.  Two states, NJ & VA, allow for carry-over of 2006 bills into 2007.  Because bill content and status change frequently, even daily, the bill status listed is simplified. 

Go to an individual state:
AL | AK | AZ | AR | CA | CO | CT | DE | FL | GA | HI | ID | IL | IN | IA | KS | KY | LA | ME | MD | MA | MI | MN | MS | MO | MTNE | NH | NV | NJ | NM | NY | NC | ND | OH | OK | OR | PA | RI | SC | SD | TN | TX | UT | VT | VA | WA | WV | WI | WY |

AL
HB 172
Rep. Johnson
Would establish a committee of pharmacists to evaluate the performance of pharmaceutical care or pharmaceutical drug utilization review, provides good faith immunity for committee members.
(Filed 3/6/07; held in committee for final day, 6/7/07) |
Study
AL
HB 174
Would allow the return of expired drugs to the distributor under certain conditions for credit or replacement.
(Filed 3/6/07; did not pass House committee 3/15/07) |
Whole
AL
HB 213
Rep. Lindsey
Would appropriate $1 million for the School of Pharmacy at Auburn Univ. "for biotechnical drug development and enhancing pharmaceutical science research leading to new drugs, complimentary to other biomedical research underway" in Alabama.
(Filed  3/07; passed House; passed Senatesigned into law by governor as Act 2007-361 6/7/07)
Research, -
AL
HB 687
 Would allow for the donation and reuse of prescription drugs and samples to charitable clinics under certain conditions.
(Filed 4/11/07; favorable report from committee 5/29/07) |
 Reuse
AL
HJR 349
 Resolution would encourage the use of electronic transmission of prescriptions from doctor to pharmacy.
(Filed;  died in committee 5/24/07) |
 
 E

AK
HB 81
Rep. Guttenberg

Would establish the Alaska Prescription Drug Task Force to consider strategies to manage the costs of prescription drugs and to increase access to affordable prescription drugs for all state residents.
(Filed 1/16/07; did not pass by end of regular session 5/16/07) |*

Study
AK
HB 82
Rep. Guttenberg
Would place requirements on pharmacies related to discount pricing including requiring that any 340B "covered entity
may not purchase a covered outpatient drug for a price that is higher thatn the 340B discounted price; requires the Department of Health and Social Services to conduct a study pertaining to prescription drug discounts and report the results to the legislature.
(Filed 1/16/07; did not pass by end of regular session 5/16/07) |*
340B, Price, Study
AK
HB 140,
SB 87
Rep. Gara
 
Would impose a beneficiary copayment of 20 percent for prescription drug costs and medical services covered under the Medicaid program for enrollees whose household income is between 250 and 350 percent of the federal poverty; would expand coverage for eligible children and pregnant women.
(Filed 1/5/07, 3/14/07; did not pass by end of regular session 5/16/07) |*
M, Price
AK
HB 148,
SB 4
Sen. Olson
Extends the Senior Care cash assistance program, but delete the existing stand-alone Rx wrap around benefit. Would providing payments of $250 a month for a senior who makes less than $9,578; $175 a month for a senior who makes between $9,578 and $12,770; $125 a month for a senior who makes between $12,770 and $22,348.
(Filed 1/07; HB 148 favorable committee report 3/12/07; did not pass by end of regular session 5/16/07)
(SB 4 passed Senate 14y-2n, 4/10/07; passed in special session 7/28/07; signed into law by governor as 1st Special Session. Chapter 1, 8/2/07 ) |
S, MMA

AZ
HB 2155
Rep. Stump

Allows for access to prescription drugs under declarations of emergency.
(Filed 1/24/07; passed House 57y-0n, 3/6/07; passed Senate 4/18/07; signed into law by governor as Chapter 207, 5/14/07) |
Emerg
AZ
HB 2255
Rep. Stump
Establishes a "continuous quality assurance program" to review pharmacy procedures for addressing pharmacy medication errors.  Defines records as peer review documents not subject to use in arbitration or civil court proceedings.
(Filed 1/18/07; passed House 46y-9n, 2/19/07; passed Senate 16y-10n, 4/18/07; signed into law by governor as Chapter 121, 4/24/07) |
E, Error,
Safety
AZ
HB 2256
Rep. Stump
Would allow for medication therapy management (MTM).
(Filed and sent to committee 1/18/07; did not pass by end of regular session 4/18/07) |
M, MTM
AZ
HB 2303
Would provides flexibility for hospitals that have pharmacy permits in purchasing and dispensing medicines.
(Filed 1/16/07; did not pass by end of regular session 4/18/07) |
 -

AZ
SB 1249
Sen. Johnson

Would require disclosure of all FDA recognized side effects be listed on a prescription for psychotropic medications.
(Filed and sent to committee 1/23/07; did not pass by end of regular session 4/18/07) |
Label
AZ
SB 1401
Sen. Hale
Would appropriate $332,000 to assist people with Medicare Part D copayments.
(Filed and sent to committee 1/25/07; did not pass by end of regular session 4/18/07) |
MMA, S
AZ
SB 1518
Sen. Burton Cahill
Would prohibit the sale of prescription information to third parties for a commercial purpose.  Allows information to be sold or transferred for medical research and other defined reasons. 
(Filed and sent to committee 1/29/07; did not pass by end of regular session 7/1/07) |
Mkt, Privacy

AZ
SB 1519
Sen. Burton Cahill

Would require full disclose of prescription drug marketing costs and gifts to prescribers over $25.  Provides for some exclusions for payments and reimbursement for expenses.
(Filed and sent to committee 1/30/07; did not pass by end of regular session 7/1/07) |
Mkt
AZ
HB 2136
Rep. Stump
Authorizes a controlled prescription drug monitoring program, including a computerized central tracking database.
(Substitute adopted, 3/16/07; passed House 6/20/07; passed Senate 5/10/07; sent to governor 6/21/07) |
Monitor, Safety
AR
SB 20
Sen. Altes

Would establish a prescription drug monitoring program.
(Filed 1/8/07; passed Senate 23y-7n, 3/8/07; died in House committee at end of session 5/1/07) |

E, Safety
AR
SB 189
Sen. Malone
Prohibits the sale of online pharmaceuticals in Arkansas if the patient hasn't consulted a prescribing practitioner.
Filed 1/25/07; passed Senate; passed House; signed to law by governor as Act 128, 2/21/07) |
Internet
AR
SB 895
Sen. Horn
Would authorize a Legislative Task Force on Patient Choice to study regulating the dispensing of prescription drugs including "a system of support for physicians and dentists within a framework of safety and accountability," impact on patient choice and "an effective regulatory scheme that would protect the public safety and ensure accountability in the drug distribution system.
(Filed 3/5/07; passed Senate 3/21/07; passed House 97y-0n, 3/28/07; signed into law by governor as Act 720, 3/3/0/07) |
Study, Whole
AR
SB 980
Sen. Horn
Would eliminate the Joint Interim Committee on Health Insurance and Prescription Drugs.
(Filed, passed Senate 3/12/07; passed House  3/28/07; signed into law by governor as Act 731 3/30/07) |
 -
AR
HB 1821
Rep. Maxwell
Would create the Arkansas Fair Trade Practices for Pharmacy Benefits Managers Act, to prohibit deceptive and unconscionable trade practices.
(Filed 2/23/07; died in committee at end of session 5/1/07) |
PBM
AR
HB 2303
Rep. Wells

Would provide flexibility for hospitals that have pharmacy permits in the purchase and dispensing of prescriptions.
(Filed 3/1/07; died in committee at end of session 5/1/07) |

340B
AR
HB 2421
Rep. Wells
Would allow a nonprofit, tax exempt, or governmentally funded hospital to obtain a pharmacy permit with certain limitations.
(Filed 3/1/07; died in committee at end of session 5/1/07) |
340B
AR
HB 2626
Rep. Sample

Provides for a "pharmacy audit bill of rights" using a state-regulated pharmacy audit process, including one week advance notice to pharmacies, requiring a pharmacist participate in clinical-related judgments, allowing use of hospital and doctor records to justify transactions, providing at least 30 days for administrative corrections and an appeal process.
(Filed and sent to committee 3/5/07; passed House 94y-6n, 3/19/07; passed Senate; signed into law by governor as Act 843, 4/3/07) |

Audit, Price
CA
AB 203
Relates to the California Discount Prescription Drug Program.
(passed Assembly; passed Senate; signed into law by governor as chapter 188, 8/24/07)
D
CA
AB 851
Assm. Brownley
Would require a pharmacist to include a large print informational insert with any dispensed prescription that poses substantial risk when taken in combination with alcohol or other medications, warning of the risks involved, as specified. Would impose a state-mandated local program.
(Filed 2/22/07; did not pass by end of regular session, 9/7/07; may be carried over to '08)*
Label

CA
AB 1276
Assm. Carnett

Would eliminate the labeling requirement pertaining to the condition for which the drug was prescribed. Requires the container to be labeled with the intended purpose of the drug if indicated on prescription if the patient desires.
(Filed 2/26/07; did not pass committee, 4/24/07; may be carried over to '08)*
Label
CA
AB 1399
Assm. Richardson

Would require a prescription drug label, upon request of a blind or visually impaired customer, to be readable by an assistive technology device for the blind or visually impaired.
(Filed 2/23/07; did not pass by end of regular session, 9/7/07; may be carried over to '08)*

Label
CA
AB 1587
Assm. De La Torre
SB 843
Sen. Calderon
Would prohibit a provider of health care, a health care service plan, contractor, or corporation and its subsidiaries and affiliates from intentionally sharing, selling, using for marketing, or otherwise using any medical information, as defined, for any purpose not necessary to provide health care services to a patient. 
(Filed; AB 1587 passed Assembly, 70y-6n, 5/27/07; did not pass Senate by end of regular session, 9/7/07; may be carried over to '08)*  (SB 843 did not pass Senate by end of regular session, 9/7/07)
Mkt, Privacy

CA
SB 400

Among other things, would require federally qualified health centers to use tamper resistant prescription pads for outpatient prescriptions.
(Filed 2/21/07 and sent to committee 9/11/07)
Label
CA
SB 472
Sen. Corbett
Adopts a standard format for the labeling of prescription drug containers dispensed in the state, that would include regulations for the font size of printed words on the label and the placement of information of the prescription and would provide that translated prescription drug labels should be made available to the patient if the patient's primary language is not English.
(Filed; passed Senate 5/29/07; passed Assembly 74y-4n, 9/5/07; signed into law by governor, 10/11/07, Chapter 470.) New item
Label
CA
SB 606
Sen. Scott
Would require a pharmaceutical company that sells, delivers, offers for sale, or gives away pharmaceutical drugs within the state to make publicly available the results of every completed clinical trial, except a phase 1 trial, for that drug, an explanation of noncompletion for any clinical trial that the company initiates or sponsors the initiation of, but does not complete, thus providing doctors and patients with additional information on the side effects and effectiveness of drugs.
(Filed 2/23/07; passed Senate 6/7/07; placed on inactive file; did not pass Assembly 9/6/07)  |
Trials
CA
SB 623
Sen. Wiggins
Would provide that the Department of Health Care Services shall pay all copayments required by drug plans under the Medicare Program for generic or brand name medications for full-benefit dual eligible beneficiaries under specified conditions. Requires the department to develop a process for the reimbursement of Medi-Cal enrolled pharmacies for the cost of the copayments, unless specified conditions are met.
(Filed 2/22/07; did not pass committee by end of regular session, 9/7/07; may be carried over to '08)*
MMA, S
CA
SB 966
Sen. Simitian
Would require every retailer of pharmaceutical drugs to have in place a system for the acceptance and collection of pharmaceutical drugs for proper waste disposal.
(Filed; passed Senate; passed Assembly 45y-30n, 9/7/07; signed into law by governor as Chapter 542 of 2007, 10/12/07) |
Safety, -
CA
AJR 31
Assm. Jones
Would urge Congress to amend the Medicare Modernization Act of 2003 to require that the federal government negotiate for the lowest available prices for prescription drugs under the Medicare Part D program, eliminate a specified gap in Medicare Part D coverage, and reduce the lifetime penalty for late enrollment in the program.
(Filed 7/2/07, adopted by Assembly 8/27/07; did not pass Senate by end of session 9/7/07*) |
MMA

CO
HB 07-1021
Rep. Frangas

Creates the prescription drug medication management program for Medicaid enrollees, providing information and technical assistance on "prudent use" of prescription drugs, avoiding drug interactions; also providing pharmacists who participate a financial incentive.
(Filed 1/10/07; passed House 2/23/07; passed Senate amended 4/25/07; signed into law by governor as Chapter 377, 5/31/07) |

CL, M
CO

HB 07-1070
Rep. Lundberg

Would repeal CO Unfair Practices Act, which provides it is against the law to sell something below market value.  The intent relates to permitting discount programs to sell gasoline and generic drugs for $4 (such as those sponsored by Target, Wal-Mart and others.)
(Filed 1/07; postponed indefinitely, did not pass committee 2/8/07; see similar HB 07-1208, signed law below) |

Generic, Price

CO
HB 07-1208
Rep. Jahn

Modifies the CO Unfair Practice Act prohibiting selling products at below cost; the change makes it unlawful only for business to sell products below cost with intent to monopolize the market for the product; requires price calculation to be based on combined total prices, not single items.  The intent relates to permitting discount programs to sell gasoline and generic drugs (such as the $4 prescription programs sponsored by Target, Wal-Mart and others.)
(Filed 1/07; amended and passed House 2/8/07; passed Senate 3/14/07; signed into law by governor 4/16/07) |
Generic, Price
CO
SB 07-1

Sen. Hagedorn

Creates the Colorado Cares Rx program to provide generic and non-patented prescription drugs to eligible uninsured residents, with annual income up to 300 percent of federal poverty guidelines, at discounted prices negotiated by the state with manufacturers and pharmacies.  The price to enrollees must be not less than AMP or actual cost and not more than WAC plus dispensing fee or the "customary charge" for the drug. Authorizes an application fee up to $20; will use voluntary participation by retail pharmacies. Appropriates $2.4 million for implementation.
(Filed 1/10/07, passed Senate 27y-6n, 1/26/07; passed House 57y-7n, 2/1/07; signed into law by governor 2/5/07) |

D

CO
SB 07-9
Sen. Tochtrop

Would transfer the Electronic Prescription Drug Monitoring Program to the Department of Public Health and Environment.
(Filed; postponed indefinitely, did not pass committee 2/7/07) |
E, Monitor

CO
SB 07-204
Sen. Tochtrop

Creates a fee from prescribers of controlled substances as an optional funding source for the state's prescription drug monitoring program, aimed at preventing overuse or abuse; also appropriates up to $31,000 for annual program operations.
(Filed 2/27/07; passed Senate; passed House 4/27/07; signed into law by governor 5/22/07) |

E, Monitor
CO
SB 07-217
Sen. Boyd
Regulates prescription drug wholesalers; including requiring criminal history background checks of applicant representatives, updating requirement for maintaining and retaining "pedigree" records to prevent or diversion to unauthorized buyers. 
(Filed 3/6/07; passed Senate 4/2/07; passed House 4/12/07; signed into law by governor 5/25/07)
Safety, Whole
CO
SB 07-231
Sen. Tochtrop

Repeals the State Board of Health's rule-making authority  for the Cancer Drug Repository Program, and authorizes a pharmacist to make the determination related to which drugs and devices are safe and requires a health care facility, medical clinic, or pharmacy that participates in the program to establish the eligibility criteria.
(Filed; signed into law by governor 5/25/07)

 Reuse
CO
EO 07-04
Gov. Ritter
Based in part on SB06-01 passed in 2006, this Executive Order establishes a "preferred drug list for non-Medicare clients receiving drugs through the fee-for-service and primary care physician programs in the Colorado Medical Assistance Program."  Requires the Department  to "evaluate the various methods by which a PDL is implemented and maintained and shall determine the best option for Colorado’s PDL; also requires obtaining supplemental rebates and an evaluation of the feasibility and cost-effectiveness of entering into one of the existing multi-state purchasing pools.
(SB06-01 passed in 2006; signed by governor as Executive Order 1/31/07) |
Bulk, M, PDL
CT
HB 5050
Rep. Witkos
Would adjust ConnPACE to include physical examinations.
(Filed and sent to committee 1/3/07; did not pass before end of regular session) |
S
CT
HB 5332
Rep. Janowski

Would increase access to chronic medication and makes their purchase more affordable by requiring insurance companies to cover 90 day supplies with one copay.
(Filed and sent to committee 1/11/07; did not pass before end of regular session)  |

 -
CT
HB 6893
Requires the Department of Social Services to establish a Communications and Outreach Program on long-term care and the Medicare Part D program, and "shall disseminate information to the public" about prescription drug benefits.
(Passed House; passed Senate; signed into law by governor as public Act 155, 6/25/07)
CL, MMA
CT
SB 53
Sen. DeFronzo
Would increase access to ConnPACE by allowing those with higher incomes to utilize the program at a graduated rate.
(Filed and sent to committee 1/3/07; did not pass before end of regular session) |
S
CT
SB 57
Sen. Crisco

Would require the licensing of pharmacy benefit managers.
(Filed and sent to committee 1/3/07; did not pass before end of regular session) |

PBM
CT
SB 74
Sen. Crisco

Requires pharmacy benefit managers to obtain a certificate of registration from the Insurance Department before operating in Connecticut; applications require a list of people running the PBM, evidence of a surety bond of at least $25,000 and a $50 annual fee. Permits the insurance commissioner to suspend, revoke, or deny registration for specified causes after notice and hearing. PBMs must apply annually for registration renewal.  PBMs run by an insurer, hospital or fraternal benefit  society are exempt from registation requirements.
(Filed; passed Senate 6/4/07; passed House 6/6/07; signed into law by governor as Public Act 07-200)

PBM
CT
HB 5484
Rep. Schofield
Would enable more seniors to qualify as Qualified Medicare Beneficiaries or Specified Low-Income Beneficiaries, thereby entitling such persons to the low-income subsidies available under the Medicare Part D program which in turn will reduce ConnPACE program expenditures by maximizing the number of ConnPACE enrollees who obtain federal low-income subsidies.

(Filed and sent to committee 1/16/07; did not pass before end of regular session) |

S
CT
HB 5507
Rep. O'Brien
Would establish a prescription drug bulk purchasing program and lower prescription drug costs through bulk purchasing.
(Filed and sent to committee 1/16/07; did not pass before end of regular session) |
Bulk
CT
HB 5632,
HB 5646
Rep. O'Brien,
Rep. Taborsak
Would expand ConnPACE eligibility to more seniors and persons with disabilities.
(Filed and sent to committee 1/17/07; did not pass before end of regular session) |
S
CT
HB 5668
Rep. Lopez Kirkley-Bey
Would require health insurers to charge the same copayment for each prescription, regardless of whether the prescription is for thirty, sixty or ninety days, provided the entire prescription is purchased at one time.
(Filed and sent to committee 1/17/07; did not pass before end of regular session) |
 -
CT
HB 6330
Rep. Olson
Would make an appropriation for a community health access management program and provide funding for the establishment of a program to connect uninsured and underinsured residents of CT to affordable health care, prescription medications and community resources.
(Filed and sent to committee 1/19/07; did not pass before end of regular session) |
CL
CT
HB 6627
Rep. O'Brien

Would establish maximum wholesale prices for prescription drugs; regulates wholesale prices for prescription drugs sold to local pharmacies in order to lower the cost for consumers.
(Filed and sent to committee 1/22/07; did not pass before end of regular session) |

Price
CT
HB 6893
Rep. O'Neill

Would establish a Communications and Outreach Program on long-term care and the Medicare Part D program.
(Filed 1/24/07; passed House 5/24/07; passed Senate 6/4/07 and signed into law by governor as Public Act 07-155)

MMA
CT
HB 7131
Would expand ConnPACE program eligibility to more residents.
(Filed and reported out of legislative commissioner's office on 3/2/07; did not pass before end of regular session)|
S
CT
HB 7324
 Would reimburse pharmacists for revenues lost due to new federal upper limits on Medicaid payments for generic drugs.
(Filed and sent to committee 3/2/07; did not pass before end of regular session) |
M, Generic
CT
SB 1, SB 3
Sen. Williams
 
Would require, as part of the Husky Kids program,  that each federally qualified health center participating in the program enroll in the federal Office of Pharmacy Affairs 340B drug discount program; deletes a 2003 deadline.
(Filed and sent to committee 2/07; did not pass before end of regular session) |
 
340B
CT
SB 147
Human Services Committee
Would require the Commissioner of Social Services to implement measures that ensure that the department's prescription drug program beneficiaries are not being denied access to needed prescription drugs due to the implementation of prior authorization requirements or the utilization of preferred drug lists.
(Filed and sent to legislative commissioner's office 3/1/07; did not pass before end of regular session)|
PDL, M
CT
SB 1189

Would require pharmaceutical manufacturing companies to report incentives given to prescribers.
(Filed and sent to committee 2/14/07; did not pass before end of regular session) | 

Mkt
CT
SB 1228
Would authorize the dispensing of prescriptions contained in a common database under specified conditions.
(Filed and sent to committee 2/20/07; did not pass before end of regular session) |
Safety
CT
SB 1229
Rep. Beldin

Would authorize pharmacies to utilize electronic prescriptions.
(Filed and sent to legislative commissioner's office 3/6/07; did not pass before end of regular session) |

E
DE
HB 105
Rep. Maier
 Would establish standards and criteria for the regulation, solvency and licensing of Pharmacy Benefit Managers.
(Filed and sent to committee 3/29/07)
PBM
DE
HB 250
Rep. Oberle
Requires the state to establish a drug rebate process for any prescription benefits provided to clients enrolled in the non-Medicaid programs administered by the division including the Delaware Healthy Children program, the Renal Disease program, the Delaware Prescription Assistance program and the Legal Non-Citizen Health programs.
(Filed; passed House and Senate; signed into law by governor as Chapter 80, 7/1/07)
PDL, S
DE
HJR 15
Rep. Miro
Joint resolution would direct the Secretary of the Delaware Department of Health and Social Services to perform a fiscal impact analysis to determine how much revenue Delaware pharmacies are expected to lose because of Medicaid's new formula that determines maximum reimbursement for multiple-source drugs, and directs the state to adopt emergency final regulations that increase the amount of reimbursement.
(Filed and passed House 37y-0n, 6/30/07; carried over to '08; sent to Senate committee 1/9/08)
M, Price
DE
SB 11
Sen. McBride
Amends the current DPAP law by providing an exception and additional opportunity for new DPAP applicants to obtain prescription drug coverage through DPAP while the applicant pursues Medicare Part D enrollment.
(Filed; passed Senate 3/20; passed House 4/4/07; signed into law by governor as Chapter 7, 4/5/07 )
MMA, S
DC
B17-0364
Councilman Catania,
 
The SafeRx Act would require licensing of pharmaceutical representatives and impose penalties for "misleading remarks made in sales pitches to doctors," intended to "counteract the influence of pharmaceutical 'detailers.'  Also would require drug-company representatives to have a bachelor's degree, adhere to a code of ethics and ban them from buying meals for physicians or giving them small gifts branded with the names of drugs or pharmaceutical companies.  Company representatives would still be allowed to give doctors drug samples.  Described by sponsors as making "the District the first in the nation" with licensing and penalties. 
Deleted from final bill: prohibiting pharmaceutical representatives from data mining, or using area prescribing data and trends as a marketing tool to target specific physicians.
News article: "D.C. Council votes to regulate pharmaceutical reps" Washington Business Journal 11/23/07.
(Filed 9/29/07; passed City Council 7y-6n, 1/8/08; signed into law by mayor as Act A17-0282, 2/1/08; requires review by US Congress) New item

Mkt
 

 



Privacy

FL
HB 565
Would rename the Medicaid Pharmaceuticals and Therapeutics committee.
(Filed  3/6/07; died in committee 5/4/07) |
M
FL
HB 893
Would prohibit the sale, manufacture, alteration, delivering, or possession of counterfeit-resistant prescription blanks for controlled substances. 
(Filed 3/6/07; died in committee 5/4/07 but substituted with H 1155 below ) |
Label
FL
HB 895

Would exempt from public records electronic prescription records for controlled substances; would allow for legitimate uses.
(Filed and sent to committee 2/23/07; died in committee 5/4/07) |

E
FL
SB 268
Would mandate the coverage of psychotropic medications when medically necessary.
(Filed 3/6/07; died in committee 5/4/07) |
 -
FL
HB 1155

Would prohibit sale, manufacture, alteration, delivery, uttering, or possession of counterfeit-resistant prescription blanks for controlled substances with intent to injure or defraud; specifies circumstances under which pharmacist who dispenses controlled  substances by mail is exempt from certain requirements governing patient ID.
(Filed 2/27/07; passed House 4/30/07; passed Senate 5/3/07; signed into law by governor 6/15/07 as 2007-156)

 Label

FL
SB 284

Would provide legislative intent to support development of FDA-recognized botanical drugs from patented complexes that "enhance effects of vaccines, helps suppress cancerous tumors and improves functioning of the human immune system;" summarizes testing procedures.
(Filed 3/6/07l died in committee 5/4/07) |
Brand, Research
FL
SB 518
 
Would prohibit sale, manufacture, alteration, delivery or possession of counterfeit-resistant prescription blanks for controlled substances; provides additional requirements for dispensing of said substance listed in Schedule II, III, or IV; provides requirements and limitations for dispensing said substances upon oral prescription; prohibits using funds from Medical Quality Assurance Trust Fund to administer.
(Filed and sent to committee 3/6/07; died but substituted HB 1155 above) |
Label
FL
SB 520

Would exempt from public-records requirements information and records reported to the Department of Health under electronic monitoring system for prescription of controlled substances listed in Schedules II-IV; authorizes certain persons and entities access to patient-identifying information; provides guidelines for use of such information and penalties for violations; provides for future legislative review and repeal.
(Filed and sent to committee 3/6/07; died in committee 5/4/07) |

Mkt
FL
SB 610
 
Would urge US Congress to support the Medicare Prescription Drug Price Negotiation Act of 2007 and allow for federal negotiation of Medicare Part D drug prices.
(Filed and 3/6/07; died in committee 5/4/07) |
MMA, Price
FL
SB 2146
 
 Would require the state to join the multistate purchasing pool for Medicaid products.  Also would require the Dept. of Elderly Affairs to study the effects of Medicare Part D benefits on Medicare enrollees.
(Filed 2/26/07; died in committee 5/4/07) |
Bulk, M, MMA, Study
FL
SB 2830
Would allow that patients have the right to choose between generic or branded prescriptions.
(Filed 3/5/07; died in committee 5/4/07) |
Generic, Brand
GA
HB 18
Rep. Stephens
Would require refund of Rx rebates from manufacturers and repeal conflicting laws.
(Prefiled 12/7/06; no further action before end of session) |
M
GA
HB 19
Rep. Stephens
Would require disclosure and refund of any Rx rebates from manufacturers that contract with the state.
(Prefiled 12/7/06; no further action before end of session) |
M
GA
HB 45
Rep. Stephens

Would prohibit prior authorization for a prescription drug which a drug manufacturer provides to a community pharmacy at the lowest price of a pricing structure.
(Filed and sent to committee 1/11/07; no further action before end of session) |

Brand, PDL, Price
GA
HB 127
Rep. Byrd
Would provide that a patient may instruct a pharmacist not to substitute a generic name drug in lieu of a brand name drug.
(Filed and sent to committee 1/24/07; passed House 3/1/07; Senate favorable report 3/28/07; no further action before end of session) |
Brand, Generic
GA
HB 285

Would require an ID to be shown prior to dispensing a controlled substance.
(Filed and sent to committee 2/8/07; no further action before end of session) |

Safety
GA
HB 367
Rep. Carter
Would allow health insurance coverage for therapeutically equivalent substitutions in certain situations.
(Filed and sent to committee 2/10/07; no further action before end of session) |
Generic, Brand
GA
HB 454
Rep. Gardner

Would require pharmacists to include the approximate retail price for an outpatient drug on the receipt for that product and repeal conflicting laws.
(Filed and sent to committee 2/14/07; no further action before end of session) |

Price
GA
HB 455
Rep. Stephens
Would enact the Georgia Prescription Monitoring Program Act to monitor dispensing of schedules II-IV.
(Filed and sent to committee 2/15/07; no further action before end of session) |
E
GA
HB 180
Rep. Rogers
Would allow that certain prescription drugs and other health care products sold by Georgia biotechnology, biopharmaceutical, or pharmaceutical companies not be subject to certain prior authorization or supplemental rebates for purposes of coverage under the state health benefit plan, medical assistance program, PeachCare for Kids, or any other health benefit plan or policy administered.
(Filed and sent to committee 1/26/07; no further action before end of session) |
Brand, M
PDL
GA
HB 550
Rep. Lindsey
Would expand certain obligations of insurers, managed health care entities, and pharmacy benefit managers.
(Filed 2/27/07; favorable committee report 3/19/07; House withdrawn, recommitted; no further action before end of session) |
PBM
GA
HB 556
Rep. Benton
Would require the prescriber's name to be printed on a prescription below his or her signature for controlled substances.
(Filed and sent to committee 2/27/07; no further action before end of session) |
Label
GA
SB 28
Sen. Hill

Would require pharmacies to submit comparative price information, to be posted on a state sponsored website.
(Filed and sent to committee 1/22/07; no further action before end of session) |

Disclose, Post, Price
GA
SB 129
Sen. Grant
Would allow limited copayments by inmates for prescription medications. Amount of copayment is not specified, but would not apply to inmates without funds in a prison account.
(Filed and sent to committee 2/10/07; no further action before end of session) |
Copay
GA
SB 150
Sen. Hill
Would provide for creation of a state website, including prescription drugs for which price information shall be collected. Such information shall include recent average wholesale prices and retail prices. If a prescription drug is available in a generic form, price data shall be reported for the generic drug and its brand name equivalent.
(Filed and sent to committee 2/13/07; no further action before end of session) |
Price, Disclose
GA
SB 178
Sen. Balfour

Would allow for mail order prescription sales under regulated conditions.
(Filed 2/20/07; passed Senate 3/20/07; withdrawn, did not pass House committee 4/2/07) |

Mail
GA
SB 205
Sen. Thomas
Enacts the "Prescription Medication Integrity Act" to provide for pedigrees for prescription drugs.
(Filed 2/27/07; passed Senate 3/28/07; passed House 4/19/07; signed into law by governor as Act 245, 5/24/07)
Safety, Whole
GA
SB 294
Sen. Murphy
Would change the criteria for substituting generic drugs for brand name drugs.
(Filed and sent to committee 3/1/07; no further action before end of session) |
Generic, Brand
HI
HR 34
HCR 54
Rep. Yamashita
Creates a task force to review the state's maximum allowable cost (MAC) program's reimbursement policy and its impact on community pharmacies.
(HR 34 Filed 3/2/07; final adopted in House, 4/12/07)
(HCR 54 filed 3/2/07; adopted by House 4/12/07; in Senate 4/24/07)
M, Price

HI
HB 6,
SB 817
Rep. Takumi

Would require quarterly reports that disclose the average wholesale price, wholesale acquisition cost, average manufacturer price, and best price for each of the manufacturer's drugs from manufacturers of certain prescription drugs dispensed.
(Filed 1/22/07; deferred in House committee 1/29/07) |
M, Price, Mkt
HI
HB 7,
SB 817
Rep. Takumi
Would direct the governor to establish the State of Hawaii's participation in the I-SaveRx prescription drug program to provide residents with increased access to affordable drugs; relates to prescription drugs.
(Filed and sent to committee 1/25/07; deleted from agenda 2/9/07) |
D, Imp
HI
HB 8, SB 819
Rep. Takumi
Would allow consumers, the State, and other affected parties to obtain an injunction, damages, and other relief when a drug manufacturer or its licensee sells prescription drugs for an excessive price.
(Filed 1/22/07; deferred in House committee 1/29/07) |
Liability, Price
HI
HB 9
SB 822
Rep. Takumi

Would prohibit the sale or transfer of patient prescription information by certain businesses as an unfair and deceptive act in the conduct of trade or commerce.
HB 9 (Filed and sent to committee 1/22/07 and deferred in House Committee) |
SB 822 (Filed and held in committee 2/6/07) |

Mkt

HI
HB 10,
SB 811
Rep. Takumi, Sen Igo

Modifies the Rx Plus state discount program and Medicaid, mandating rebate agreements between drug manufacturers and Department of Human Services using "best efforts to obtain a rebate amount equal to or greater than the amount of any discount, rebate, or price reduction for prescription drugs provided to the federal government,"  also requiring the Department to inform health care providers about drug costs for manufacturers with rebate agreements and those without rebate agreements.
Filed, HB 10 passed House 3/1/07; amended; passed Senate 4/10/07; vetoed by governor 4/27/07; House override 46y-3n; Senate override 18y-4n;  became law by veto override as Act 60, 5/3/07)
D, M, PDL, Price
HI
HB 11
SB 814
Rep. Takumi

Would require prescription drug advertisements to meet Federal standards, public disclosure of clinical trial information, and drug manufacturers to pay fees to Department of Health to fund a public education initiative on clinical trials and drug safety.
(Filed and sent to committee 1/22/07; deferred by committee 2/2/07) |

Trials
HI
HB 12
Rep. Takumi
Would require the Director of Human Services to establish a pharmacy best practices and cost control program, including Medicaid and other state public assistance health benefits plans, in which any public and private health plan may participate; includes a prescription drug preferred list and prior authorization review process.
(Filed and sent to committee 1/25/07; deferred by committee 2/7/07) |
Bulk, M, PDL
HI
HB 370,
SB 232
Rep. Lee
Would establish remote dispensing pharmacy regulations.
(Filed and referred by committee 1/22/07) |
 -
HI
HB 817,
SB 1195
Rep. Mizuno
Would appropriate funds for the Sage PLUS program, which provides assistance at no charge to people receiving Medicare and Medicaid benefits and near-retirees, to expand services to the neighbor islands and to support the program's operating costs. House amended effective date to July 2020.
HB 817 (Filed, passed House and sent to Senate 3/6/07; referred by committee 3/23/07) |
SB 1195 (Filed, sent and referred by committee 2/15/07) |
MMA, CL
HI
HB 1321,
SB 1407
Rep. Say
Would establish licensing and solvency requirements for prescription drug plans that are offering a pharmacy benefit pursuant to Medicare Part D.
HB 1321 (Filed, sent to and referred by committee 1/24/07) |
SB 1407 (Filed sent to and referred by committee 2/16/07) |
MMA

HI
HB 1359
SB 1445
Rep. Say

Would create a Hawaii State Pharmacy Assistance program by merging the current State Pharmacy Assistance program which coordinates the Medicare Part D drug benefit and the Hawaii Rx Plus program under a single comprehensive Hawaii State Pharmacy Assistance program umbrella.  Would allow 340B qualified entities to use telepharmacy if there is no other pharmacy within 5 miles.
HB 1359 (Filed, passed House 3/6/07; passed Senate 25y-0n & sent to conference comm, 4/10/07)
D, MMA, S, M, 340B, PDL.
HI
HB 1478
SB 1729
Rep. Green
Would extend income eligibility requirement to 200% of the federal poverty level; Would require the department to provide enrollees with counseling about prescription drug plans; would repeal prescription drug rebate funding limitations; relates to state pharmacy assistance program.
HB 1478 (Filed and sent to committees 1/24/07, 2/16/07)
D, S
HI
SB 257
Would prohibit pre-signed and predated prescriptions.
(Filed, passed Senate 3/6/07; deferred by House committee 3/22/07) |
Label
HI
SB 816
Sen. Ige

Would require the Director of Human Services to establish a pharmacy best practices and cost control program including Medicaid and other state public assistance health benefits plans, in which any public and private health plan may participate; includes a prescription drug preferred list and prior authorization review process; requires drug manufacturers to disclose economic benefits of $25 or more provided to persons who prescribe, dispense, or purchase prescriptions.
(Filed, passed Senate 3/6/07; amended, deferred by House committee 3/29/07) |

Mkt, PDL,
ID
HB 158
Health & Welfare
Amends existing law relating to patient medical information and prescription confidentiality to provide that disclosure of patient specific information to law enforcement authorities is not prohibited if made pursuant to a search warrant, subpoena or other court order. Effective 7/1/07.
(Filed 2/9/07; passed House 67y-0n; passed Senate 34y-0n, 3/13/07; signed into law by governor as Chapter 140, 3/21/07)
Privacy
ID
HB 164
Health & Welfare

Would allow mail order pharmacies to reduce the number of days per week they must provide toll-free phone service for purposes of customer service and patient communication.
(Filed; both passed House 67y-0n, 2/26/07; did not pass Senate 4/11/07) |

Mail
ID
SB 1146
 
Would change existing law relating to wholesale drug distribution to provide a short title; to require licensure of wholesale drug distributors; to provide for licensing requirements; to provide for limitation on disclosure of information; to provide restrictions on transactions; to require each person who is engaged in wholesale distribution of prescription drugs to provide a pedigree.
(Filed and sent to committee 2/12/07; did not pass Senate 4/11/07) |
 Whole
ID
SB 1184
Judiciary and Rules Comm.
Requires state licensure of drug wholesalers and requires a product pedigree including detailed recordkeeping .
(Filed 3/1/07; passed Senate 31y-4n, 3/8/09; passed House; signed into law by governor as Chapter 319, 3/30/07) |
Whole

ID
HJM 1

Non-binding memorial requesting the U.S. Secretary of Health and Human Services to amend, if not eliminate, the Phased-Down State Contribution or "clawback" payments relating to pharmacy benefits for Medicare and Medicaid programs.
(Filed and adopted by House and Senate 2/26/07) |
M, MMA
ID
SJM 104
Sen. Werk
Non-binding memorial stating findings of the Legislature and requesting the Congress of the United States to enact legislation requiring specific content for prescription drug advertising with name-brand drug identifications.
(Filed and sent to committee 2/12/07; did not pass Senate 4/11/07) |
Mkt
IL
HB 157
HB 301
HB 1513
Would amend the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act. Provides for an annual increase in the household income amounts used to determine eligibility for a grant, the increase being equal to the cost-of-living increase designated under the federal Social Security Act.
(Filed and sent to committee 3/23/07; did not pass before end of session) |
S, Tax
IL
HB 732
Would establish a pilot program in Kane County to provide funding for and coordination of specialty health care services, pharmaceutical drug assistance, and diagnostic testing for individuals who are not eligible for medical assistance under the Illinois Public Aid Code and who do not have other health insurance coverage.
(Filed and sent to committee 2/7/07, passed House 3/2/07, passed Senate 5/16/07 and sent to governor; Amendatory Veto by governor 8/13/07, may be subject to further legislative action*) |
D
IL
HB 691
Would state that prescribers may not prescribe medications for patients via the Internet, WWW, phone or fax unless the patient has been physically examined by the prescriber or has been given a documented patient evaluation, including any medical history and physical exam for the condition prescribed.
(Filed and sent to committee 2/8/07; passed House 3/28/07 and sent to Senate; did not pass before end of '07 session*) |
E, Internet
IL
HB 813

Would establish a cancer drug repository program to which people may donate cancer drugs or supplies to be used by individuals who meet criteria set by the Department of Health. Also sets forth requirements that cancer drugs or supplies must meet in order to be accepted and dispensed under the program.
(Filed and sent to committee 2/7/07; passed House 3/21/07; no further action before end of '07 session*) |

Reuse
IL
SB 86
HB 3601
Would amend the Senior Citizens and Disabled Persons Property Tax Relief and Pharmaceutical Assistance Act and increase the household income eligibility limitations for grant year 2007, and provides that, for grant years 2008 and thereafter, the limitations shall be increased annually by the percentage increase in the Consumer Price Index for the previous calendar year.
(Filed and sent to committee 1/31/07; did not pass before end of session) |
Price, Disclose
IL
HB 872
Would create a Prescription Drug Ethical Marketing Act that would require every manufacturer and labeler in the state to disclose the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional activities by the company, directly or through its pharmaceutical marketers, to any physician, or any other prescriber in the state.
(Filed and sent to committee 2/7/07; dic not pass before end of session) |
Mkt
IL
HB 1082
Would create the online clearinghouse to be known as the State of Illinois Prescription Drug Price Finder to provide a Drug Price that identifies the 50 most commonly prescribed drugs in Illinois and their usual and customary prices.
(Filed and sent to committee 2/8/2007; passed House 3/22/07; postponed in Senate; did not pass before end of session) |
CL, Price
IL
HB 1248
Would allow the symptom to be put on the prescription bottle label.
(Filed and sent to committee 2/9/07; did not pass before end of session) |
Label 
IL
H 1257
Rep. Feigenholtz
Amends the Pharmaceutical Assistance Act. Provides for beneficiaries who have a diagnosis of HIV or AIDS. Provides for covered prescription drugs by the Medicare Part D Prescription Drug Plan in which the beneficiary is enrolled.
(Filed; passed House; passed Senate; signed into law by governor as Public Act 95-208, 8/16/07)
S
IL
HB 1459
Would amend existing code and law to prohibit the licensure, transfer, use or sale of any records relative to prescription information containing patient-identifiable or prescriber-identifiable data by any licensee or registrant of the Acts for commercial purposes.
(Filed and sent to committee 2/21/07; did not pass before end of session) |
Privacy, Mkt
IL
HB 1461
Amends pharmaceutical assistance programs so that covered prescription drugs includes any agent or drug added by the Department of Healthcare and Family Services within the therapeutic categories of antipsychotics, antidepressants, and anticonvulsants.
(Filed and sent to committee 2/21/07; did not pass before end of session) |
M

IL
HB 3005

Would make a technical change in a Section concerning pharmacy payments under the Medicaid program.
(Filed and sent to committee 2/26/07; did not pass before end of session) |
M
IL
HB 3689
Would amend the wholesale drug distribution licensing procedure.
(Filed and sent to committee 3/1/07; did not pass before end of session)|
 Whole
IL
SB 30
Would establish an electronic monitoring program for schedules II, III, IV and V controlled substances.
(Filed and sent to committee 2/7/07; passed Senate 5/30/07; passed House 5/30/07; signed into law by governor as Public Act No. 95-442, 6/28/07)|
E
IL
SB 509
Would create a whole licensure and prescription medication integrity act.  Would mandate licensure for wholesalers and those that ship Rx into the state.
(Filed and sent to committee 2/8/07; passed Senate 5/8/07; final action deadline extended for House until 7/31/07 on 6/30/07) |
Whole
IL
SB 595
Sen. Koehler
 
Creates a program in the Dept. of Aging to help those over age 60 with managing their medications.
(Filed 2/8/07; passed both chambers 5/31/07; signed into law by governor as Public Act 95-0535, 8/28/07) |
Safety, -
IL
SB 705

Makes it illegal to alter a prescription or possess blank prescription pads without the permission of prescriber, and attempt to fill prescriptions that are from an unauthorized prescriber. 
(Filed 2/8/07, amended by committee;  passed both chambers 5/31/07; signed into law by governor as Public Act 95-0487, 8/28/07)

Label
IL
SB 726
Would allow the cost of a prescription reading machine or machine that makes audible prescription labels to be tax deductible.
(Filed and sent to committee 2/8/07; no further action before end of session) |*
Tax

IL
HB 915, HB 948,
HB 1089, HB 1176,
HB 2581, HB 2988,
HB 2989, HB 2990,
SB 86, SB 524,
SB 1195

Would amend the state Pharmaceutical Assistance programs (SPAP) by adjusting enrollee benefits and eligibility, including wrap around benefits tied to Medicare Part D.
(All filed and sent to committees 2/07; none had further action before end of session) |*
 

D, MMA, S, Tax
IL
SB 1518

Would require PBMs or other parties that contract with the state to be legally responsible for payment of a health care claim.
(Filed and sent to committee 2/9/07; passed Senate 3/21/07 and sent to House; no further action before end of sesison) |*

PBM
IL
SB 147
Would create the Pharmaceutical Best Price Buying Initiative Act and amends the Freedom of Information Act and the Illinois Public Aid Code. Creates the Pharmaceutical Best Price Buying Initiative Program. Requires the Department of Healthcare and Family Services to negotiate prescription drug discount agreements with drug manufacturers to provide discounts for drugs purchased by pharmacies and drug wholesalers participating in the program.
(Filed and sent to committee 1/31/07; did not pass out of committee by end of session) |*
D, Price
IN
HR 87

 Would create an interim committee to study Pharmacy Benefit Managers.
(Filed 4/27/07)

 PBM, Study
IN
H 1001
FY08 budget would appropriate $7.9 million for the IN Prescription Drug Program.
(Filed; passed House 4/29/07; passed Senate 4/30/07; signed into law by governor 5/11/07) |
S
IN
HB 1008
Among other things, would provide for an aggregate prescription drug purchasing plan for state employees.
(Filed and sent to committee 2/23/07; did not pass out of committee by end of session) |
Bulk
IN
HB 1390
Would  create requirements that apply to a pharmacy benefit manager; makes a violation of the requirements an unfair and deceptive act or practice in the business of insurance.
(Filed and sent to committee 1/16/07; did not pass out of committee by end of session) |
PBM 
IN
HB 1584
Would allow a practitioner to deliver to a patient through a community or migrant health center or maternal and child health clinic a drug sample that is not more than five years past the expiration date.
(Filed and sent to committee 1/23/07; did not pass out of committee by end of session) |
Sample
IN
HB 1642

Would require the office of Medicaid policy and planning to adjust prescription dispensing fees based on a survey of pharmacy providers and apply for any Medicaid state plan amendment needed for the dispensing fee adjustment.
(Filed and sent to committee 1/23/07; did not pass out of committee by end of session) |

 M, Price
IN
HB 1784
Would require physicians, dentists, hospitals, and certain other health care facilities to provide consumers with the price of common health care procedures; requires certain health care facilities to provide consumers with the price of commonly prescribed drugs.
(Filed and sent to committee 1/26/07; did not pass out of committee by end of session) |
Price
IN
SB 201
Would remove the requirement that the drug utilization review board provide a report concerning the preferred drug list for Medicaid recipients to the select joint commission on Medicaid oversight; repeals provisions requiring the office of Medicaid policy and planning to conduct a survey of pharmacy providers to assess the appropriate level of pharmacy dispensing fees.
(Filed and sent to committee 1/8/07; passed Senate 2/26/07; did not pass out of house committee by end of session) |
PDL
IN
SB 318

Would allow the office of Medicaid policy and planning to implement a change in the office's maximum allowable cost schedule for prescription drugs seven days after the office posts the changes on the office's Internet web site, replacing current law requiring 45 days before the change may be effective).
(Filed and passed Senate 2/22/07; did not pass out of committee by end of session) |

M, Price
IA
HF 506

Would provide for prescription drug retail price comparison.
(Filed and sent to committee 2/22/07; did not pass before end of session) |

Price
IA
HF 204
Would create "fair market pricing" and establish a prescription drug card program.
(Filed and sent to committee 2/6/07; did not pass before end of session) |
D, Price
IA
HF 798
 Would provide regulations for Pharmacy Benefit Managers.
(Filed and sent to committee; did not pass in this form; was substituted with SF 512) |
 PBM
IA
HF 909
FY 2008 budget requires the Mediciad department to "reimburse pharmacy dispensing fees using a single rate of $4.52 per prescription, or the pharmacy's usual and customary fee, whichever is lower. Beginning July 1, 2007, the department shall adopt rules to adjust the pharmacy dispensing fee to compensate for any reduction in the drug product cost due to the federal DRA.
(Passed House; passed Senate; signed into law by governor, 5/29/07)
M
IA
SF 111

 Would allow online prescription drug retail price comparison.
(Filed and sent to committee 2/6/07; did not pass before end of session) |

Internet, Price

IA
SF 67

Regulates the practice of pharmacy, including providing for the establishment of a limited drug and device distributor license.
(Filed and sent to committee 1/30/07, passed senate sent to house 3/5/07; passed House 3/13/07; signed into law by governor 3/23/07) Chapter No. 2007-19 |
Whole

IA
SF 109

Regulates pharmacy benefits managers and provide penalties.
(Filed and sent to committee 1/29/07; passed Senate 2/6/07; passed House 2/13/07; signed into law by governor 2/22/07) |
PBM
IA
SF 512

Creates regulations for Pharmacy Benefit Managers and provide penalties.
(Filed, passed Senate and House 4/27/07; signed into law by governor 5/25/07) Chapter No. 2007-193 |

PBM
IA
SF 25,
SSB 1037
Would provide for the establishment of a limited drug and device distributor license.
(Filed and sent to committee 1/30/07) |
Whole
IA
SSB 1047
Would regulate pharmacy benefit management companies.
(Filed and sent to committee 1/17/07) |
PBM
IA
SSB 1089
Would regulate pharmacy benefits managers.
(Filed and sent to committee 1/24/07; See SF 512)
PBM
KS
HB 2392
Would require pharmacy wholesalers and distributors to be registered with the state.
(Filed and sent to committee 2/6/07; did not pass committee by end of session)|
Whole
KS
HB 2416
 
Would enact the prescription monitoring program model act, intended to improve the state’s ability to identify and stop diversion of prescription drugs.
(Filed and sent to committee 2/7/07; did not pass committee by end of session) |
Monitor, Safety
KS
HB 2542,
SB 357
House Appropriations Committee; Senate W & M
Would specify that "expenditures shall be made from the 'Prescription Support for Community Based Primary Care Clinics' account for: (1) Purchase of drug inventory under 340B of the federal public health service act for community health center grantees and federally qualified health center look-alikes who qualify; (2) increasing access to prescription drugs by subsidizing 340B patients on a sliding fee scale."
(Filed and sent to committee 1/07; HB 2564 passed House 79y-44n, 3/16/07; SB 357 passed Senate 26y-14n, 3/21/07; held in conference committee, did not pass 5/4/07)
(S 357 passed Senate 3/23/07; amended to delete Rx provision & passed House 5/2/07; signed into law by governor with pharmaceutical policy deleted, 5/21/07) |
340B, D
KS
SB 357
FY08 budget section 13 provides for a review of the impact of changes in Medicaid dispensing fees due to federal DRA changes, and specifies that  the agency "shall adjust dispensing fees as necessary to meet federal guide-lines and maintain total medicaid reimbursement to pharmacies at current levels" in FY 2008.
(Amended; signed into law by governor 5/21/07) |
M
KS
SB 229
Would create the Prescription Confidentiality Act.
(Filed and sent to committee 1/31/07; did not pass committee by end of session) |
Privacy, Mkt
KS
SB 272

Would establish the duties for the pharmacy benefit managers and create penalties for violations.
(Filed and sent to committee 2/6/07; did not pass committee by end of session) |

PBM
KY
HB 252
Rep. Burch
Would require certification from pharmacists, wholesalers and distributors that imported drugs pose no additional risk to public health and safety and would result in a reduction in the cost of prescription drugs. 
(Filed 2/7/07; favorable report 2/20/07; did not pass by end of regular session 3/27/07) |
PBM, Import, Whole
KY
HB 256
Rep. Burch
Would declare that the I-SaveRx program allows residents to save on the most common brand-name prescription drugs from an approved list of foreign pharmacies and provides immunity to the state from liability of any injury or damage caused by products purchased through the program. 
(Filed  2/7/07; did not pass by end of regular session 3/27/07) |
Brand, Import
KY
SB 88
Sen. Stivers
Makes it illegal to obtain a controlled substance without a prescription.  Also keeps certain records and information private.
(Filed; passed Senate 2/7/07; passed House 99y-0n, 3/12/07; signed into law by governor as Act 124, 4/5/07)
E, Privacy
KY
SB 215
Sen. Denton
Would define authentication, normal distribution channel, pedigree, wholesale distribution, and wholesale distributors.  Would require licensure of wholesalers and require distributors to maintain a pedigree for each drug distributed.
(Filed 2/21/07; did not pass by end of regular session 3/27/07) |
Whole, Safety
KY
HR 125
Rep. Hall

Would urge the Federal government to improve the Medicare Part D benefit by administering it through Medicare, close the gap in coverage, repeal the ban on negotiating drug prices, simplifying the program and improving the low income subsidy.
(Filed  2/13/07; did not pass by end of regular session 3/27/07) |

MMA, Price
KY
SJR 48
Sen. R. Jones
Authorizes real time access to the Kentucky All Schedule Prescription Electronic Reporting program (KASPER) drug monitoring program, aimed at reducing abuse of prescription products, and facilitates reciprocal communication with similar programs in other states.
(Filed and adopted by Senate 2/20/07; adopted by House 3/7/07; signed into law by Governor as Acts Ch. 15, 3/19/07) |
E, Monitor, Safety
LA
HB 38,
HB 57
Rep. Robideaux

Provides for a new limit on individual income tax rates and repeals state sales tax and use exemptions provided for prescription drugs.
(Filed 2/16/07; withdrawn, did not pass 4/30/07) |

Tax
LA
HB 523
Rep. Thompson
Prohibits pharmacists from issuing a prescription based solely upon the results of an electronic questionnaire.
(Filed 4/19/07; passed House 5/16/07; passed Senate 6/24/07; signed into law by governor as Act 318 7/9/07)
E, Internet, Safety
LA
HB 535
Rep.. Anders
Creates the Aging and Disability Information Station program; providing that the state assist people with adult-onset disabilities in accessing and applying for manufacturers' discount cards, pharmaceutical assistance programs, and other supports and service programs.
(Filed 4/19/07; passed House 102y-0n, 5/8/07; passed Senate 39y-0n, 6/13/07; signed into law by governor as Act 406 7/10/07) 
CL
LA
HB 680
Rep. Durand
Provides that within Medicaid, antipsychotic and Hepatitis C drugs be included in the Louisiana prior authorization process and preferred drug list, for an estimated annual savings of $9.1 million in 2007-07.  [see fiscal note]
(Filed 4/20/07; passed House 98y-0n, 5/8/07; passed Senate 36y-0n, 6/13/07; signed into law by governor as Act 107 6/22/2007)
Brand, Generic, M, PDL
ME
HP 5 / LD 4
Rep. Faircloth

Would prohibit  the sale of pharmaceutical information that identifies directly or indirectly the practitioner who ordered the prescription drug; establishing a mechanism for confidentiality protection through an opt-out procedure, comparable to the federal "Do Not Call List," utilizing the licensing and relicensing process for prescribers. The procedures include methods for filing with the Maine Health Data Organization to protect confidentiality of prescriber-identifying information by restricting its use to non-marketing purposes.
(Filed 1/3/07; passed House; passed Senate 6/20/07; signed into law by governor as Publlic Law Act 460, 6/29/07)
NEWS UPDATE ME: Medical data law disputed in lawsuits by The Associated Press, Portland Press Herald, 8/31/07.  Companies that collect, analyze and sell medical data filed lawsuits Wednesday in federal courts in Maine and Vermont, challenging laws in the two states that make doctors' prescription-writing habits confidential.

Privacy
ME
HP 25 / LD 22
Rep. Beaudoin
Would require health professionals to distribute free samples of Rx to patients in order to test reaction and effectiveness in treatment.
(Filed 1/3/07; did not pass committee; dead 2/13/07)*
-
ME
HP 89 / LD 97
Rep. Campbell
Would require the attachment of expiration dates to prescription drugs dispensed by pharmacists, providing protection for patients and allowing use of the drugs only to the date supported by the highest standards of pharmacology and scientific research.
(Filed and sent to committee 1/9/07; did not pass committee; dead 2/13/07)*
Label
ME
HP 294 / LD 364
Rep. Campbell
Would prohibit the use of false or misleading prescription drug advertisements in the State by prescription drug manufacturers and also prohibits the use of language recommending the public to ask physicians about the use of any prescription drug.
(Filed and sent to committees 1/25/07, 2/6/07; did not pass committee; dead 5/15/07)*
Mkt
ME
HP 321 / LD 405
Rep. Lewin
Would direct the Department of Health and Human Services to amend the rules for MaineCare reimbursement to pharmacies for prescription drugs in order to increase the dispensing fee on a basis that is indexed to the Consumer Price Index and to provide other increases in reimbursement.
(Filed and sent to committee 1/30/07; did not pass committee by end of regular session 6/20/07)*
M, Price

ME
HP 327/LD 411
Rep. Perry

Provides $300,000 funding for the Maine Drug Enforcement Agency to establish a pilot program for return of unused prescription drugs by mail consistent with the recommendations of the Maine Drug Return Implementation Group established in Public Law 2003, chapter 679.
(Filed 1/30/07; passed House 6/11/07; passed Senate 6/12/07; 6/21/07; signed into law by governor as Special Act Chapter 27, 6/29/07)

Reuse
ME
HP 302 / LD 386
Rep. Hinck
Would create an electronic prescription drug monitoring system; concerns funding; prevents unauthorized collection, use, sale or exchange of confidential patient prescription information for commercial use, financial gain or unauthorized purposes; provides penalties.
(Filed 1/30/07; did not pass committee; dead 4/24/07)*
Mkt, E
ME
HP 332/ LD 416
Rep. Treat

Creates "An Act To Protect Seniors and the Public from Unfair Health Insurance Sales Practices" providing additional Part D consumer protections to seniors.
(Passed House; passed Senate 4/4/07; signed into law by governor as Public Law Chapter 53, 4/17/07) |
 

MMA, S 
ME
HP 607 / LD 807
Rep. Treat
Requires a pharmacy benefits manager or insurer shall require a contracted pharmacy to charge to an enrollee or insured person the pharmacy's usual and customary price of filling the prescription or the contracted copayment, whichever is less.
(Passed House; passed Senate; signed into law by governor as Public Law Chapter 431, 6/27/07)
PBM, Price 
ME
HP 638 / LD 839
Rep. Treat
Creates a Prescription Drug Academic Detailing Program to enhance the health of residents of the State which would encourage better communication between the health Department and prescribers participating in publicly funded health programs. Aims to reduce health complications and unnecessary costs associated with inappropriate drug prescribing.
(Filed 3/1/07; passed House 136y-0n, 6/12/07, 6/15/07; passed Senate 6/13/07; signed into law by governor as Public Law Chapter 327 of '07, 6/19/07) |
Detail, Mkt
ME
HP 857 / LD 1176
Rep. Pinkham

Would prohibit Medicaid drug formulary decisions from being based solely on the negotiated rebate from the manufacturer or other financial benefits that the State would receive from having or deleting the product from the Medicaid formulary.
(Filed 3/8/07; did not pass committee; dead 4/2/07)*
 

Brand, M, PDL
ME
HP 1009 / LD 1440
Rep. Treat
Creates "An Act To Prohibit Inappropriate Software Advertising of Prescription Drugs" intended to eliminate marketing messages from electronic prescribing software.  It prohibits the sale or use of prescribing software that seeks to direct health care providers, through advertising or messaging, to prescribe a specific drug or use a specific pharmacy. 
(Filed 3/1/07; passed House 6/11/07; passed Senate 6/12/07; signed into law by governor as Public Law Chapter 362, 6/20/07) |
Mkt, Privacy
ME
SP 290 / LD 902
Sen. Brannigan
Adds Medicare prescription drug plan sponsors and pharmacy benefits managers to the definition of payors.
(Filed 3/1/07; passed Senate; passed House; signed into law by governor as Public Law Chapter 136, 5/18/07) |
 
MMA, PBM
ME
SP 372 / LD 1120
Sen. Mills

Would impose cost sharing (premiums and copayments) for prescription drugs in the MaineCare program consistent with the provisions of the federal Deficit Reduction Act of 2005.
(Filed 3/6/07; did not pass committee by end of regular session 6/20/07)*

M
MD
HB 281
Del. Hubbard

Requires the Department of Public Safety and Correctional Services to provide access to a 30-day supply of medication to inmates being released, to provide stability once the inmate is free. Requires the Mental Hygiene Administration to reimburse mental health case workers for evaluating inmates set for release within three months.
(Filed 1/31/07; passed House 3/30/07/07; passed Senate 4/4/07; signed into law by governor as Chapter 595, 5/17/07) |

-
MD
SB 266
Sen. Lenett

Would prohibit the transfer of information that identifies a specified prescriber or patient on a prescription; provides exceptions; requires the Secretary of Health and Mental Hygiene to adopt regulations and enforce requirements regarding the transfer of information on a prescription.
(Filed 1/30/07; unfavorable report, did not pass committee 3/12/07) |

Mkt, Privacy
MD
HB 734
Del. Rudolph

Would prohibit a pharmacy benefit manager from establishing a reimbursement amount based on the type of prescriber, or imposing a specified copayment, deductible, limit on quantity, or other conditions.
(Filed 2/8/07; did not pass committee by end of regular session 4/9/07) |

PBM
MD
HB 847
Del. Bromwell
SB 596
 
Provides for the regulation by the Maryland Insurance Commissioner of specified discount medical plan organizations and discount drug plan organizations; requiring the registration of such entities as discount medical plan organizations or discount drug plan organizations incuding application and renewal process for registration; allows for consumer to cancel within 30 days.
(SB 596 filed; passed Senate 3/29/07; passed House 3/29/07; vetoed by governor as duplicitive 5/17/07) |
(HB 847 Filed 2/9/07; passed House; passed Senate; signed into law by governor as Chapter 629, 5/17/07) |
D
MD
HB 1025
Del. Rudolph
Would allow anyone who qualifies for the Maryland Rx Program to be eligible to participate (automatic enrollment) and be responsible for the cost of the drugs purchased by or for them.  Allows the state to recoup any start up funds from savings achieved for participating individuals.
(Filed 2/9/07; withdrawn; did not pass committee 3/13/07) |
D
MD
HB 1030
SB 759
Would make changes to wholesaler requirements to include inspection and bond.  Also would require a pedigree for drugs or devices distributed in the state.
SB 759 (Filed and sent to committee 2/9/07; passed Senate and House 4/2/07; signed into law by governor on 5/8/07, Chapter 352)
HB 1030 (Filed and sent to committee; passed Senate 4/3/07; passed House 4/5/07; signed into law by governor on 5/8/07, Chapter 353)
Whole
MD
HB 1033
Del. Taylor
Would prohibit insurers from imposing a copayment requirement for a covered drug or device that exceeds the retail price of the drug or device.
(Filed  2/9/07; passed House 139y-0n, 3/16/07; passed Senate 47y-0n, 3/29/07; signed into law by governor on 5/13/07, Chapter 638)
Copay, Price
MD
HB 1073,
SB 859
Del. Manno, Sen Raskin
Would allow a deduction for prescription expenses for a person eligible for Part D to 7.5% of federal adjusted gross income if the person itemizes, aimed at aiding those making "donut hole" out-of-pocket payments
(Filed 2/9/07; did not pass committee by end of regular session 4/9/07) |
MMA, S, Tax
MD
HB 1169
Del. Rudolph
Would establish the Maryland "P3 program" to study prescription drug policy for diabetes and diabetics.
(Filed 2/19/07; withdrawn; did not pass committee 3/22/07) |
Study
MD
HB 1370
Del. Mizeur
Would require a person to enroll in a specific prescription drug plan or Medicare Advantage Plan in order to be eligible for the Senior Prescription Drug Assistance Program; authorizing the Program to limit payments of specified subsidies under specified circumstances and extending date of operations.
(Filed 3/2/07; passed House 136y-0n, 3/22/07; passed Senate 47y-0n, 4/4/07l signed into law by governor on 5/17/07, Chapter 509) |
MMA, S
MD
SB 281
Sen. Middleton
Would authorize funds to be transferred and appropriated to the Department of Health and Mental Hygiene in fiscal year 2008 for providing a grant up to $425,000 to the Maryland Medbank Program as a clearinghouse for access to Rx drugs.
(Filed and passed Senate 2/26/07; passed House 3/31/07; vetoed by governor as duplicitive 5/17/07) |
CL
MD
SB 596

Would require specific medical and drug discount plans to be registered with the state.
 

D -
MD
SB 729
Sen. Kelley
Would allow MD Medical Assistance Program enrollees to are prescribed atypical antipsychotic medications that are subject to prior authorization to automatically receive a 30-day supply of medication and not be subject to a waiting period.
(Filed 2/16/07; withdrawn, did not pass committee 3/9/07)
M
MD
SB 824
SB 972
Sen. Middleton
Would cap the subsidy and extend the termination date of the Senior Prescription Drug Program until Dec. 31, 2009.
(Filed 2/21/07; SB 824 passed Senate 43y-0n, 3/16/07; passed House 137y-0n, 3/29/07; signed into law by governor 5/17/07 Chapter 508)
(SB 972 did not pass before end of regular session) |
MMA, S
MD
HJR 1
Non-binding resolution, would urge Federal government to pass legislation to allow HHS to negotiate with manufacturers for Medicare Part D products.
(Filed and sent to committee 2/7/07; withdrawn 3/14/07) |
MMA, Price
MD
SJR 1
 
Would urge the Maryland Congressional Delegation to support federal legislation that would clarify that pharmaceutical companies may assist specified Medicare Part D beneficiaries through pharmacy assistance programs.
(Filed and sent to committee 1/31/07; passed Senate, sent to House 2/14/07; did not pass by end of regular session) | 
MMA
MD
SJR 8

Would urge the Maryland Congressional Delegation and the President of the United States to enact legislation to simplify premiums, deductibles, copayments, and formularies in plans made available to Medicare beneficiaries, to eliminate the coverage gap in the Medicare Part D prescription drug benefit, and to repeal the parts of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 that prevent negotiating lower drug prices.
(Filed and sent to committee 2/22/07; passed Senate, sent to House 3/25/07; did not pass by end of regular session) |

MMA
MA
H 1, H 4000, H 4001,
S 3, S 2250
Gov. Patrick
FY08 budget (§ 8) would allow the Department of Elder Affairs, within the Prescription Advantage wrap around for Medicare Part D, to adjust cost sharing guidelines to reflect cost changes that are a result of pricing adjustments made by pharmaceutical suppliers.
(Filed 2/28/07; did not pass in this form; also see signed law H. 4141 below)
MMA, S
MA
H 66
Rep. S. Walsh
Would expand requirements for safeguarding and monitoring prescription drugs.
(Filed 1/10/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Safety, Whole
MA
H 372
Rep Reinstein
Would prohibit certain advertising by pharmaceutical companies.
(Filed  1/5/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Mkt 
MA
H 602
Rep. Hingham
 Would allow 3 month supply prescription for those in Prescription Advantage program.
(Filed  1/11/07, sent to study on 10/29/07; did not pass committee by end of 2007 formal session; carried over to '08*)
 S
MA
H 603
Rep. Correia

Would extend the Medicare Part D safety net by authorizing emergency 30-day supplies for enrollees once each calendar year.
(Filed 1/5/07; did not pass committee by end of 2007 formal session; carried over to '08*)

MMA
MA
H 2911
Rep. Frost
Would provide for an income tax deduction for prescription drug costs.
(Filed 1/2/07; did not pass committee by end of 2007 formal session; carried over to '08*)
S, Tax
MA
H 1005,
S 1275,
S 1309
Rep. Mariano;
Sen. Moore

Would prevent the sharing of prescription data and protect the confidentiality of patient prescription records.
(Filed 1/8/07; H 1005 sent to Joint committee on Financial Services, 10/3/07; did not pass committee by end of 2007 formal session; carried over to '08*)

Mkt, Privacy
MA
H 1036,
Rep. McCarthy
Would create requirements providing "equity in the provision of prescription drug coverage" with same financial and quantity terms for in-store purchases and mail-order purchases.
(Filed 1/10/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Mail
MA
H 1074
Rep. Scaccia
Would require "disclosing in writing the wholesale price of the drug being delivered as well as the exact co-pay or contribution being made on the consumer's behalf" by an insurer or third party payer.
(Filed  1/10/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Label, Price
MA
H 1163
Rep. Sannicandro
Would require the state to request a federal waiver for the office of Rx Information to act as an agent for residents in providing information on purchase of prescription drugs from state and Canadian sources.
(Filed 1/10/07; accompanied a study order, H4038, 5/17/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Imp
MA
H 1170 
Rep.  Straus
Would provide for state-coordinated bulk purchasing of prescription drugs.
(Filed 1/10/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Bulk

MA
H 602, H 1146,
H 3771
Rep. Bradley,
Rep. Koczera

Would amend the Prescription Advantage subsidy program.  H3771 would extend the open enrollment period.
(H 3771 Filed and sent to committee on Elder Affairs 1/10/07)
(H 602 & (H 1146, accompanied a study order: http://www.mass.gov/legis/185history/h04319.htm 10/24/07; did not pass committee by end of 2007 formal session*)

S, MMA
MA
H 2249
Rep. Smola
Would require typed or printed Pharmacy Prescriptions.
(Filed and sent to committee 1/9/07; held in committee 6/27/07)
Label, Safety

MA
H 2120, H 2146,
H 2182, H 2240,
H 2242, H 891,
H 4000 amendment #606,
S 1311
Rep. Scibak, Rep. Jones

Would provide for health care facilities and hospice programs to return certain unused pharmaceutical drugs.
(Filed and sent to committee 1/10/07; held in committee)
Reuse
MA
H 2153,
Rep. Koutoujian
Would expand wholesale licensure and prescription medication integrity requirements.
(Filed and sent to committee 1/10/07; held in committee 6/27/07)
Safety, Whole
MA
H 2160
Rep. Koutoujian
Would establish procedures for internet prescription consumer protection.
(Filed and sent to committee 1/10/07; held in committee 6/27/07)
Internet
MA
H 2166,
S 420
Rep. Koutoujian, Sen. Moore

Would establish collaborative drug therapy management, including initiating, monitoring, modifying and discontinuing of a patient's drug therapy by a pharmacist in accordance with a collaborative practice agreement with a physician or other prescriber.
(Filed and sent to committee on Elder Affairs 1/10/07)

MTM
MA
H 2197
Rep. Marzilli
Would establish a "counter-detailing" program, to "inform prescribers about drug marketing that is intended to circumvent competition from generic or other therapeutically equivalent pharmaceutical alternatives or other evidence-based treatment options.
(Filed and sent to committee 1/10/07; held in committee 5/2/07)
Mkt
MA
H 2243 
Rep. Scibak
Would require certain health care entities to participate in the 340B prescription drug discount program.
(Filed and sent to committee 1/10/07; held in committee 6/27/07)
340B
MA
H 2251 
Rep. Spellane
Would provide for the disclosure of certain gifts made by pharmaceutical companies.
(Filed 1/9/07 and sent to committee 9/12/07)
Mkt
MA
H 1163  
H 2090
Rep. Fennell,
Rep. Sannicandro
Would create a Office of Pharmacy Information, authorized to provide information on purchasing prescription drugs in the state or from Canada.
(Filed and sent to committee 1/9/07; held for study)
CL, Imp
MA
H 4000
House Ways & Means
 

Sec. 37 would allow the Elder Affairs Dept. to modify the Prescription Advantage subsidy program, authorized cost sharing required of enrollees (co-payments, premiums and deductibles) to reflect price trends.  Restates ernollment requirements in Medicare Part D if eligible.
(Favorable report by W&M Comm 4/11/07; did not pass in final budget) |

340B, S
MA
H 4141
Conference Comm.

FY 2008 state budget provides:
A) The state Health Care Financing agency is authorized to change the pricing formula for generic and multiple-source drugs to achieve savings forthe state publicly aided programs.
B) funds for the Prescription Advantage "SPAP" subsidy program of $63.8 million, including a policy that no copayments or deductibles may be increased expect by majority vote of the legislature; clarifies that the state covers wrap around benefits for Medicare Advantage and no-Part D crediable coverage plans; also requires enrollment to remain open throught the year. (in §46)
C) payments to community health centers for pharmaceutical services provided to uninsured individuals including "the office shall pay community health centers a base rate that shall be no less than the then-current federal Medicare FQHC rate, including "the office shall add payments for additional services not included in the base rate, including 340B pharmacy." (in §39)
D) $233.9 million for the Medicaid program's dual-eligible pharmaceutical "clawback" payment.
(Amended by Conference Committee, anacted; signed into law by governor as Chapter 61 of 2007, 7/12/07)

340B, M, MMA, S,
MA
S 3H 4141
item 4000-0500

FY08 budget authorizes a CMS Medicaid Transformation Grant to fund a MassHealth e-Prescribing pilot project to introduce electronic prescription writing (e-prescribing) to Medicaid providers for developing, piloting, evaluating and rolling out a real-time decision support solution that can be integrated into providers’ workflow that will be accomplished by integrating prior authorization, preferred drug lookup, and other components of Affiliated Computer Services’ (ACS is MassHealth’s claims processing contractor) application used by MassHealth providers with the Rx Gateway for prescription routing and related services already under development by MA-SHARE (Massachusetts Simplifying Healthcare Among Regional Entities)
   Line item 4100-0060 authorizes state agency to adjust pharmacy dispensing fees for multiple source prescription drugs "to compensate for any reduction as a result of the upper limits implemented under the Deficit Reduction Act of 2005."
(Filed 2/07; passed Senate and to Joint Conference Comm. 5/25/07; signed into law by governor as Chapter 61 of 2007, 7/12/07)

E, M, Price
MA
S 3
Senate Ways & Means

FY08 budget floor amendments: #17 - ban on gifts to prescribing physicians.
#67 - retaining a Medicare Part D "Safety Net" for dual eligible Medicaid enrollees.
#68 - "Prescription advantage affordability", deleting the ability of Elder Affairs agency to raise co-payments or premiums.
(Filed 5/19/07, #17, 67 and 68 rejected/did not pass in Senate 5/25/07)

Mkt, MMA, S

MA
S 394,
S 412
Sen. Barrios,
Sen. Montigny

Would "promote prescription drug affordability" by require the state to implement a program to purchase prescription drugs from Canada when such purchases become legal under federal law.
(Filed 1/9/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Imp, Price
MA
S 411
Sen. Montigny

Would establish the Massachusetts "prescription drug fair pricing program", using bulk purchase, a "statewide, uniform preferred drug list of covered products" and negotiated prices for prescription drugs. Would include the development of educational programs, including a counterdetailing program and "the utilization of any available cost containment tools" such as cliincal management, prior authorization refill controls and Rx monitoring. 
(Filed 1/10/07; ; did not pass committee by end of 2007 formal session; carried over to '08*)

Bulk, D, PBM, PDL, Price
MA
S 413
Sen. Montigny
Would restore the Medicare Part D safety net prescription drug coverage for seniors and the disabled.
(Filed 1/10/07; favorable report from Joint Committee on Elder Affairs 10/25/07; did not pass committee by end of 2007 formal session; carried over to '08*)
MMA, S
MA
S 419
Sen. Moore
Would relate to the safe administration of medications and legible prescriptions reducing medication and Rx errors.
(Filed 1/9/07; favorable report from Joint Committee on Elder Affairs 10/25/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Label, Safety
MA
S 428
Sen. Tolman
Would affect prior authorizations of prescription medications.
(Filed 1/9/07; favorable report from Joint Committee on Elder Affairs 10/25/07; did not pass committee by end of 2007 formal session; carried over to '08*)
M, PDL
MA
S 432
Sen. Tucker
Would require pharmacies to inform the Department of Public Health of medication dispensing errors.
(Filed committee 1/9/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Safety
MA
S 433
Sen. Tucker
Would provide continuity of prescription drug coverage under the Mass. Health Reform Act of 2006, requiring coverage of each specific prescription medication being prescribed to said insured as of the initial date of the insured's coverage under the policy that is equal to the most favorable coverage rate for any prescription medication under the policy.
(Filed 1/10/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Brand, Generic
MA
S 564
Sen. Baddour
Would require insurance companies to cover voice sythesizer prescription containers for people who are legally blind or visually impaired.
(Filed 1/10/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Label
MA
S 614
Sen. Moore
Would allow for equitable pharmacy benefits between in person pharmacies and mail order pharmacies.
(Filed 10/3/07; ; did not pass committee by end of 2007 formal session; carried over to '08*)
Mail
MA
S 644
Sen. Tolman
Would require insurance companies to provide large type prescription bottles for the visually impaired.
(Filed 1/10/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Label
MA
S 1250
Sen. Moore
Would relate to drug samples, requiring all patients be given full information on the product and requiring marketers to maintain written records identifying the manufacturer and the person who distributes any complimentary starter doses to prescribers, to be made available to the state upon request.
(Filed  1/9/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Mkt, Sample
MA
S 1252
Sen. Moore
 Would require certain health care professionals to file prescription ethics and responsibility confirmation statements.
(Filed 1/10/07; 9/12/07; ; did not pass committee by end of 2007 formal session; carried over to '08*)
 Mkt
MA
S 1274
Sen. Moore
Would require certain health care professionals to file prescription ethics and responsibility confirmation statements.
(Filed 1/9/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Mkt
MA
S 1745
Sen. Tisei
Would create new tax credits for prescription drugs.
(Filed 1/15/07; did not pass committee by end of 2007 formal session; carried over to '08*)
Tax, D
MA
S 2143
Sen. Spilka
Non-binding resolution to the U. S. Congress relative to the advertising of drugs by pharmaceutical companies.
(Filed 1/8/07; did not pass committee by end of 2007 formal session*)
Mkt
MI
HB 4044
SB 43
Rep. Simpson

Would repeal law providing manufacturer immunity from liability for drugs that have been approved by U.S. Food and Drug Administration.
(Filed, passed House and sent to Senate 2/22/07; held in Senate 12/12/07; carried over to '08*)

Liability
MI
HB 4045
Rep. McDowell

Would allow lawsuits within three years of repeal of state law that had prohibited suits once drugs were approved by U.S. Food and Drug Administration.
(Filed, passed House 60y-49n, 2/22/07; held in Senate 12/07; carried over to '08*)

Liability
MI
HB 4046
 
Would clarify liability for inaccurate representation concerning risks of drugs, medications and supplements.
(Filed, passed House 58y-49n, 2/22/07; held in Senate 12/07; carried over to '08*)
Liability
MI
HB 4094
Would enter Michigan into a Midwest Pharmaceutical Compact.
(Filed and sent to committee 1/23/07)
Bulk
MI
HB 4115

Would enact the Prescription Drug Fair Pricing Act.
(Filed and sent to committee 1/24/07)

D, Price
MI
 HB 4344
Rep. McDowell

Appropriations bill, Sec. 1620  deletes the requirement that an optional mail-order pharmacy program be available in Medicaid, replacing it with intent language that if the department realizes savings resulting from the way in which the Medicaid program pays pharmacists for prescriptions from average wholesale price to average manufacturer price the savings shall be returned to pharmacies as an increase in the dispensing fee. The increase can be no greater than $2.00.
(Filed 2/28/07, passed House and Senate; signed into law by governor as Public Act 123, 11/1/07) |

 M, Price

MI
SB 525

Would create a website to educate consumers about prescription prices and to provide links to public and private program websites regarding access to discounted or free prescription drug products; relates to generically equivalent drug products for brand name drug products; relates to pharmacy benefits managers.
(Filed  5/23/07, passed Senate 26y-6n, 8/1/07; held in House 12/07*)
 Price, generic, brand, PBM
MI
SB 717
Would modify certain criteria regarding pharmacy labeling and require the prescriber's name on the bottle.
(Filed and sent to committee 9/4/07)
Label
MN
HF 183 
Would provide limited medical assistance coverage for individuals eligible for Medicare Part D.
(Filed and sent to committee 1/17/07; did not pass before end of '07-'08 sessions) |
 MMA
MN
HF 282,
SF 1233
Would provide an exception for pharmaceutical products to a state "Unfair Practices" law prohibiting sales below cost where competition exists.
(Filed and sent to committee 1/22/07; did not pass before end of '07-'08 sessions |
Price
MN
HF 399
SF 900

Would establish the Long-Term Care Patient Access to Pharmaceuticals Act.
(Filed and sent to committee 1/29/07; passed Senate 4/23/07 and sent to House; did not pass before end of '07-'08 sessions)
(HF 399 Filed and sent to committee; did not pass before end of '07-'08 sessions |

-
MN
HF 1041
Would establish a controlled substances prescription electronic reporting system.
(Filed and sent to committee 2/15/07; did not pass before end of '07-'08 sessions) |
E

MN
HF 1076
SF 971
HF 1073
HF 1078

Would require the Commissioner of Human Services to provide notice when a prescription drug is removed from the formulary.
(Filed and sent to committee 2/19/07)
HF 1078 (Filed, passed House 5/25/07; passed Senate 5/16/07; signed into law by governor 5/27/07 with numerous line-item vetoes) |

M, PDL
MN
HF 1722
Would change the pharmacy dispensing fee.
(Filed and sent to committee 3/5/07; did not pass before end of '07-'08 sessions) |
M
http://www.legislature.state.tn.us/bills/currentga/asp/WebBillInfo/BillCompanionInfo.aspx?BillNumber=hb12
* = NJ & VA provide for carryover of 2006 bills to 2007 under some circumstances; 25 states provide for some carryover from 2007 to 2008.
| (on the status line) = No further action taken in 2007.
Top of page

In this table, legislation that has passed all chambers and parliamentary steps are shaded in yellow.  These include measures that have been signed into law by governors, laws passed without signature of a governor, measures pending final action by governors or vetoed by governors, as well as legislative resolutions adopted but not requiring executive branch approval.  A bold green highlight such as "signed into law by governorindicates the final and formal step. 

MN
HF 1849
Would not allow an online or patient survey to be enough to allow a prescription to be filled in the state and requires an actual medical condition and/or exam.
(Filed and sent to committee 3/8/07; did not pass before end of '07-'08 sessions) |
E
MN
HF 1984
 Would allow the return of prescription drugs from pharmacies in certain situations.
(Filed and sent to committee 3/12/07, did not pass before end of '07-'08 sessions) |
Reuse
MN
SF 2
Among other things, would change medical assistance coverage for Medicare Part D co-payments, create a prescription drug discount program, and co-payments for medical assistance care.
(Filed and sent to committee 1/4/07; did not pass before end of '07-'08 sessions) |
Copay, D, MMA
MN
SF 71
Would eliminate the co-payments for medical assistance and general assistance medical care and would cover Medicare Part D co-payments for dual eligibles.
(Filed and sent to committee 1/11/07; did not pass before end of '07-'08 sessions) |
Copay, MMA
MN
SF 73

Would create a prescription drug discount program.
(Filed and sent to committee 1/11/07; did not pass before end of session) |

D
MN
HF 708

Among other things, would require the commissioner of human services to reimburse low-income Medicare enrollees for Medicare Part D cost-sharing and out-of-pocket costs and provides limited medical assistance coverage for individuals eligible under Medicare Part D.
(Filed and sent to committee 2/8/07; did not pass before end of session) |

MMA, S
MN
SF 714
Would establish a prescription electronic reporting system for controlled substances.
(Filed and sent to committee 2/12/07; did not pass before end of session) |
E
MN
SF 896
Would extend prompt payment requirements to pharmacy benefit managers and pharmacies.
(Filed and sent to committee 2/15/07; did not pass before end of session) |
PBM
MN
SF 900

Would establish the Long-Term Care Patient Access to Pharmaceuticals Act.
(Filed and sent to committee 2/15/07; did not pass before end of session) |

 -
MS
HB 121
Rep. Barnett
Prescription drugs; would provide for drug repository program for donated drugs.
(Filed 1/3/07; died in committee 1/30/07) |
Reuse
MS
HB 528
Rep. Dedeaux
 
Reauthorizes the 2004 law requiring that the state develop and implement methods, sometimes termed "counter-detailing," to provide to Medicaid providers information about the costs to the Medicaid program of single source drugs and innovator multiple source drugs, and information about other generic drug choices and the comparatives costs to the Medicaid program of those alternatives.  Reaffirms and reenacts the 2004 law that required Medicaid to "establish a mandatory preferred drug list (PDL), with drugs not on the list to "be made available by utilizing prior authorization;" also requires mandatory generic substitution and affirms a 5-drug cap or limit per month only two of which may be brand name products.  Re-authorizes establishing relationships with other states for bulk purchasing, as well as negotiations with other countries "if allowed by federal law or regulation."
(Filed; passed House; passed Senate 3/13/07; signed into law by governor, 4/20/07 )
Brand, Bulk, Generic, Import, M, PDL, Price
MS
HB 1128
Rep. Eaton
Would mandate that pharmacy benefit reimbursement contracts must include reasonable costs incurred by pharmacies in dispensing and labeling.
(Filed 1/3/07; died in committee 1/30/07) |
PBM
MS
HB 1439,
SB 3041
Rep. Holland
Would allow for freedom of choice, known as "any willing provider" for patients in long-term care facilities, providing they "shall have the same rights and privileges concerning pharmacy providers as participants or beneficiaries of health benefit plans."
(Filed 2/12/07; HB 1439 passed House; passed Senate; signed into law by governor,  3/26/07)
-, AWP
MS
SB 2107
Sen. Williamson
Would enact the "Pharmaceutical Marketing Disclosure Law," requiring Rx manufacturers to disclose gifts, fees, payments, subsidies or other economic benefits to health care providers in connection with promotional or marketing activities.
(Filed; died in committee 1/30/07) |
Mkt
MS
SB 2116 
Sen. Wilemon
Would require the results of clinical trials of drugs to be registered with health care providers.
(Filed 1/3/07; died in committee 1/30/07) |
Trials
MO
HB 544
Would establish the Missouri Pharmacy Benefits Managers' Fair Trade Practice Act which specifies guidelines for pharmacy benefit managers wishing to conduct business in Missouri.
(Filed and sent to committee 1/23/07; did not pass before end of session) |
PBM
MO
HB 339
Would change the laws relating to wholesale distributors of prescription drugs.
(Filed and sent to committee 1/11/07; did not pass before end of session) |
Whole
MO
HB 212
 Would allow insurance customers to pay the lower of the insurance copayment or the usual and customary retail price of the prescription drug.
(Filed and sent to committee 1/3/07; did not pass before end of session)
 -
MO
HB 696

Would require health insurers to notify enrollees in writing of all changes to prescription drug formularies on an annual and quarterly basis.
(Filed and sent to committee 2/1/07; did not pass before end of session) |

PDL
MO
SB 291
Would relate to wholesale distributors of prescription drugs.
(Filed and sent to committee 1/22/07; did not pass before end of session) |
Whole
MO
HB 333
Would create a Prescription Drug Monitoring Program Act to monitor the prescribing and dispensing of controlled substances.
(Filed and sent to committee 2/8/07; did not pass before end of session) | 
E
MO
SB 680
Would regulate pharmacy benefit managers.
(Filed and sent to committee 3/5/07; did not pass before end of session) |
PBM
MT
SB 94
Removes the requirement that wholesale and retail non-prescription manufacturers be licensed and regulated entities through the state.
(Filed and sent to committee; signed into law by governor 5/3/07 as Chapter No. 395) |
Whole, -
MT
HB 536

Would create the wholesale licensure and Prescription Medication Integrity Act.
(Filed and sent to committee 2/1/07; passed Senate 4/14/07, passed House 4/19/07, Vetoed by governor, 5/3/07; veto override failed 6/7/07) |

Safety, Whole
MT
SB 326
Sen. Schmidt
Would create a controlled substance prescription drug database and a prescription drug monitoring program.  Would provide for referral for administrative sanctions for failing to submit information or knowingly disclosing information.
(Filed, passed Senate and sent to House 2/28/07; died in committee 4/27/07) |
E, Mkt 
NE
LB 308
Would adopt the Automated Medication System Act.
(Filed and sent to committee 1/16/07; did not pass before end of session) |
Auto
NE
LB 400

Would require an audit of Medicaid drug rebate payments.
(Filed and sent to committee 1/17/07; did not pass before end of session) |

M, Price

NE
LB 451

Would change provisions relating to release of patient information by a pharmacist.
(Filed and sent to committee 1/17/07; indefinitely postponed 5/31/07) |
Mkt
NE
LB 577
Would provide for reimbursement for generic prescriptions.
(Filed and sent to committee 1/18/07; indefinitely postponed 5/31/07) |
Generic
NE
LB 675
Would require disclosures by pharmaceutical manufacturing companies.
(Filed and sent to committee 1/19/07; indefinitely postponed 5/31/07) |
Mkt
NE
LB 699
Would enact the Healthy Nebraska Rx Card Program Act.
(Filed and sent to committee 1/19/07; indefinitely postponed 5/31/07) |
D
NV
AB 6
Assm. Hardy
Authorizes a board of county commissioners to enter into a contract to provide residents of the county with discounts on prescription drugs.
(Filed 12/6/06; sent to committee 2/5/07; passed Assembly 4/18/07, passed Senate 5/17/07, signed by governor 5/25/07, as Chapter 117) |
D
NV
AB 128
Assm. Conklin
Would require certain wholesalers and manufacturers of prescription drugs to file annually with the Office of the Attorney General a report disclosing certain economic benefits that the wholesalers and manufacturers have provided to certain persons; expands provisions concerning the confidentiality of the contents of a prescription to prohibit disclosing names of prescribers.
(Filed and sent to committee 2/20/07; passed Assembly 5/22/07, passed Senate 5/31/07, signed by governor 6/13/07 as Chapter 409) |
Mkt, Privacy, Whole
NV
AB 84
Assm. Hogan
Would prevent prescribers from using an earlier expiration date on the label of the container for a prescription drug than the one specified by the manufacturer.
(Filed and sent to committee 2/9/07, did not pass before end of session) |
Label
NV
AB 232
SB 197
Would require pharmacies to publish prices of commonly used prescription drugs.
(Filed and sent to committee 3/1/07; passed Assembly 6/1/07, passed Senate 6/3/07, signed by governor 6/14/07 as Chapter 519) |
Price
NV
AB 235
Would allow the symtpom or purpose of a prescription to be on the label if the patient desires.
(Filed and sent to committee 3/1/07; passed Assembly 4/17/07, passed Senate 5/23/07, signed by governor 5/25/07 as Chapter 203) |
Label
NV
SB 231
Would state that prescription records are not considered public records and would prohibit any person who has access to the

contents of a prescription on file in a pharmacy from divulging any of the contents of the prescription to any person with certain exceptions.
(Filed and sent to committee 3/7/07; did not pass before end of session) |

Privacy, Mkt
NH
LSR 260/
SB 61
Would require pharmaceutical manufacturers to disclose certain information to the secretary of state
(Filed and sent to committee 2/1/07; failed to pass Senate 4/12/07) |
Mkt

NH
HB 567

Would regulate pharmacy benefit manager.
(Filed and sent to committee 1/4/07; ought not to pass 11/13/07)
 PBM
NH
LSR 578/
HB 386
Would establish a pharmaceutical marketing disclosure law.
(Filed and sent to committee 1/4/07; failed to pass House 3/21/07)|
Mkt
NH
HB 615
Would permit a state pharmacist to dispense a ninety-day supply of a prescription drug, with no price differential for a nonresident or mail order pharmacy.
(Filed and sent to committee 1/29/07; failed to pass House 4/14/07) |
Mail, Price
NH
LSR 579 
HB 697
 Would relate to responsible prescription drug advertising.
(Filed and sent to committee 2/12/07; failed to pass House 3/27/07) |
Mkt
NH
LSR 580 
HB 628
 Would establish the New Hampshire Rx advantage program.
(Filed and sent to committee 2/7/07; retained in committee for action in second year of session 4/5/07) |
D, S
NH
HB 148
Rep. Rosenwald

Establishes a commission to study Rx costs and the 340B Federal Drug Pricing Program.
(Filed, passed House and Senate 2/15/07; signed into law by governor as Chapter 245, 6/28/07)

340B, Study
NH
LSR 867/
H 158
 Would allow covered persons to purchase an up to 90 day supply of life sustaining drugs.
(Filed and sent to committee 1/22/07; passed both houses 5/10/07; signed into law by governor as Chapter 73 6/11/07) |
-
NH
HB 630,
LSR 640
Would establish an electronic controlled drug prescription monitoring program.
(Filed and sent to committee 2/9/07; retained in committee for action in second year of session 3/20/07) |
E
NH
LSR 143,
HB 831
Would require pharmacies to notify consumers when their prescriptions will need to be renewed before they may be refilled.
(Filed and sent to committee 2/21/07; failed to pass House 3/27/07) |
 
NH
HB 517
 Would establish a pharmaceutical drug assistance program.
(Filed 1/4/07; passed both houses on 6/13/07; signed into law by governor 7/13/07 as Chapter 297) |
S
NJ
A 2537,
S 1396
Assm. Conaway,
Sen. Buono
Establishes the "New Jersey Prescription Drug Retail Price Registry" in the Department of Health and Senior Services (DHSS) for the purpose of making retail price information for the 150 most frequently prescribed prescription drugs readily available to New Jersey consumers.
(Filed 2/23/06; AB 2537 and AB 2656 combined; AB 2537 passed Assembly 72y-3n, 6/8/06; AB 2537 substituted for SB 1396; AB 2537 passed Senate 40y-0n, 6/22/06; final passage Asembly 7/8/06; signed into law by governor as Chapter 84 of 2006, 8/21/06) |
Price
NJ
A 3734
 Would require state health benefits program to use bulk purchasing.
(Filed and sent to committee 11/20/06)
Bulk
NJ
A 3735
 Would require state health benefits program to inform physicians about generic prescription drugs.
(Filed and sent to committee 11/20/06)
Generic
NJ
A 3405,
S 339
Would upgrades tampering generally with prescribed medicine to second degree crime under certain circumstances.
(Filed and sent to committee 1/22/07, substituted by S 339 3/12/07, passed both houses 4/30/07signed into law by governor, P.L.2007, c.69.)
Safety

NJ
A 3875
Asm. Van Drew
S 2421

Would establishes prescription and over-the-counter drug abuse public awareness campaign; designated "Jason's Law."
(Filed and sent to committee 1/9/07)
Safety

NJ
S 1604
A 1624
Asm. Conaway

Would establish a prescription drug monitoring program to consist of electronic monitoring of any controlled dangerous substance dispensed by a pharmacists in an outpatient setting.
(Filed and sent to committee 2/22/07, passed senate sent to assembly 3/12/07)

E
NJ
S 2307 
A 2951
Would establish "Prescription Drug Right to Know Act" and clinical trial registry to require pharmaceutical companies to publicly disclose clinical trial data. Trials
NJ
S 2370
A 301
Asm. Cohen
Would require fee for service prescription benefits for NJ Family Care Program.
(Filed and sent to committee 12/4/06)
S
NJ
S 2914
A 1904
Would establish the NJ Rx Program to reduce prescription drug prices.
(Filed and sent to committee 11/8/07)
 D, S
NJ
AR 226
Asm. Conaway
Would memorialize CMS to ensure that Medicare beneficiaries that were auto-enrolled into Medicare Part D receive assistance to enroll in 2007.
(Filed and sent to committee 11/20/06)
MMA
NJ
SR 75
Sen. Buono
Would memorialize Congress and the President to enact legislation to eliminate the Medicare Prescription Drug coverage gap.
(Filed and sent to committee 9/15/06)
MMA
NM
HB 46
Rep. Heaton
Would allow for prescription medication donations.
(Filed 1/24/07; passed House 61y-0n, 2/8/07, postponed indefinitely(died))|
Reuse
NM
HB 320
Rep. Wirth
Would require that the current retail price of a prescription drug be provided upon request.
(Filed 1/22/07, passed House 63y-2n, 2/7/07, did not pass Senate 14y-21n, 3/20/07) |
Price
NM
HB 482
Rep. Heaton
Would provide for a state-regulated pharmacy audit process, including two weeks advance notice to pharmacies, requiring a pharmacist participate in clinical-related judgments, allowing use of hospital and doctor records to justify transactions, providing at least 21 days for administrative corrections and an appeal process. Effective 7/1/07.
(Filed 2/21/07; passed House 66y-0n; passed Senate 34y-0n; signed into law by governor 3/13/07)
Audit, Price
NM
HB 566
Rep. Bratton
Would require authorization by an attending physician for dispensing of a multi-source generic drug or substituting a prescription product included on the FDA therapeutic equivalence evaluation list.
(Filed and sent to committee 1/25/07; did not pass committee by end of regular session 3/20/07)|
Brand, Generic
NY
AB 29
SB 86
Sen. Padavan
Would provide for the proper packaging and labeling of prescription drugs and created penalties for intentional fraudulent tampering and forgery.
(Filed 1/3/07*)
Label

NY
AB 566

Would mandate that every policy that covers prescription drugs cover any drug most likely to provide relief.
(Filed and sent to committee 1/3/07, enacting clause stricken; did not pass Assembly 4/20/07) |
 Brand, -
NY
AB 656
Asm. Christensen
Would establish a drug repository program to accept and dispense donated, unused prescriptions and exempts the donors and dispensers from criminal tort or liability.
(Filed and sent to committee 1/3/07)*
Reuse
NY
AB 840
Asm. Englebright

Would prohibit the disposal of Rx in a landfill and require Rx manufacturers to establish Rx collection programs to accept unused or expired Rx from consumers for environmentally friendly disposal.
(Filed and sent to committee 1/3/07*)

 -
NY
AB 1014
Asm. Gottfried
Would restore medical assistance wrap around coverage for Medicare Part D drugs.
(Filed and sent to committee 1/3/07*)
MMA
NY
SB 118
Sen. Golden
Would provide for cost of living and marriage penalty adjustments to EPIC Rx program.
(Filed and sent to committee 1/3/07*)
S
NY
SB 316
Sen. Golden

Would create a prescription drug program where suppliers pay rebates for drugs purchased by participants at retail rates.
(Filed and sent to committee 1/3/07*)

D, S
NY
SB 323
Sen. Golden
Would establish the Rx bulk purchasing cooperative program to reduce the cost of Rx.  Would also improve access and provide educational outreach. (Filed 1/3/07) Bulk
NY
SB 455
Sen. Golden
Would provide the Rx reimportation protection program for the investigation of the sale of unsafe Rx including internet sales.
(Filed and sent to committee 1/3/07)
Imp, Safety
NY
AB 1279
Asm. Englebright

Would provide that residential health care facilities may return and redistribute unused medication.
(Filed and sent to committee 1/3/07)

Reuse
NY
AB 1396
Asm. Grannis

Would provide that an individual shall not become ineligible under the Elderly Pharmaceutical Indemnity Program due to an increase in Social Security benefits or a public or private pension.
(Filed and sent to committee 1/5/07, enacting clause stricken and did not pass 4/20/07)|

S
NY
AB 1401
Asm. Grannis
Would require a drug description, including the color, shape and any identification code or markings, to be included on the label of the prescription drug.
(Filed and sent to committee 1/5/07, enacting clause stricken and did not pass 4/20/07) |
 Label
NY
AB 1547
Asm. Brodsky

 Would expose manufacturers of prescription drugs or medical devices, who engage in direct to consumer advertising, to civil liability where adequate warnings are not provided; provides factors that may be considered in determining whether the warnings were adequate.
(Filed and sent to committee 1/10/07)

Liability, Mkt
NY
AB 1550
Asm. Brodsky

Would require manufacturers and labelers of prescription drugs dispensed in the state that engage in marketing activities in this state to annually report marketing expenses to the Department of Health; imposes a $10,000 civil fine for failure to report.
(Filed and sent to committee 1/10/07)

Mkt
NY
AB 1654
Asm. Englebright
Would provides for cost of living and marriage penalty adjustments to eligibility standards for the EPIC Rx program.
(Filed and sent to committee 1/10/07)
 S
NY
AB 1757
Asm. Crouch
Would authorize a pharmacist to substitute a brand name prescription drug for the generic equivalent of such drug if requested to do so by the patient; if done the pharmacist must record the request.
(Filed and sent to committee 1/11/07)
 Brand, Generic
NY
AB 2076
Asm. Jacobs

Would require the state board of pharmacy, in conjunction with the state consumer protection board, to prepare and publish a guide explaining the purpose, function and availability of generic drugs; requires prescribers of drugs not approving a generic substitution to inform the patient of the reasons for such non-approval.
(Filed and sent to committee 1/12/07)

Brand, Generic
NY
AB 2202
Asm. John
Would direct the Office of General Services to study and report on procurement strategies and practices that may lower the cost of prescription drugs to the state, municipalities, and state residents.
(Filed and sent to committee 1/16/07)
Study
NY
AB 2249
Asm. Ortiz
Would establish the Medicaid prescription senior eligibility expansion program in order to extend prescription drug coverage to qualified Medicare beneficiaries and special low-income medicare beneficiaries.
(Filed and sent to committee 1/16/07)
MMA, S
NY
AB 2274
Asm. Jacobs
Would require all pharmaceutical clinical trials and studies to be posted on a website to provide public with full disclosure; provides definitions; requires the commissioner to collect and post; monitor the website for compliance; provides public service announcements; imposes $25k fine for violators; requires annual reporting to the legislature.
(Filed and sent to committee 1/16/07; amended and recommitted to codes 4/25/07)
Trials
NY
AB 2441
Asm. Weprin
Would exclude from the definition of "income" the out of pocket expenses for all medical and prescription drugs not reimbursed or paid for by insurance in determining eligibility for the real property tax exemption relating to the Senior Citizen Rent Increase Exemption.
(Filed and sent to committee 1/17/07)
Tax
NY
AB 2519
Asm. McDonough

Would require prescriptions to be typewritten, electronically printed or handwritten in ink or indelible pencil in a legible manner; requires that handwritten prescriptions shall only be written in print letters; prohibits the use of script letters in handwritten prescriptions.
(Filed and sent to committee 1/17/07)

Label
NY
AB 2573
Asm. Grannis
Would prohibit insurers, HMO's and health plans from charging a copayment for a prescription drug which is higher than the usual and customary cost of such drug.
(Filed and sent to committee 1/17/07; enacting clause stricken and did not pass 4/20/07) |
Price
NY
AB 2758
Asm. Mayersohn
Would make it illegal to knowingly alter, mutilate, destroy, obstruct, obscure or remove, by means of a sticker, tag or other device used to deter theft, or a price sticker, or otherwise, the whole or any part of the label including where applicable the expiration date displayed thereon, of any over-the- counter drug or cosmetic.
(Filed and sent to committee 1/19/07)
Label
NY
AB 2808,
Asm. Colton
AB 3213
Asm. Barra
Would prohibit health insurers from requiring that the insured purchase prescribed drugs from a mail order pharmacy or pay a co-pay fee when such purchases are not made from a mail order pharmacy if a similar fee is not charged for drugs from a mail order pharmacy.
(Filed and sent to committee 1/19/07)
Mail, Price
NY
AB 2896
Asm. V. Lopez

Would provide that medical assistance for prescription drugs shall be limited to reimbursable amounts for comparable generic drugs if generic drugs are available throughout the state.
(Filed and sent to committee 1/19/07)

Price, M

NY
AB 2943
Asm. Lavelle
AB 7422
Asm. Hyer-Spencer

Would increase the income limits on the elderly pharmaceutical insurance coverage (EPIC) program for single people and for married couples.
(Filed and sent to committee 1/22/07)
S
NY
AB 3305
Asm. Zebrowski
Would require the drug information label required pursuant to federal food and drug administration rules and regulations shall have usage and warning labels which shall be marked, stamped, tagged or branded in legible and conspicuous English words in at least sixteen point print.
(Filed and sent to committee 1/24/07)
Label
NY
AB 3598
Asm. Gottfried
Would authorize the commissioner of health to create a system to incorporate co-payments billed to a recipient under Medicare Part D towards the recipient's total annual co-payments under medical assistance.
(Filed and sent to committee 1/26/07)
M, MMA
NY
AB 3601
Asm. Grannis
Would enact requirements relating to the safe handling of prescription drug samples by certain health care professionals; requires maintenance of certain records and information regarding samples received and distributed including expiration dates.
(Filed and sent to committee 1/26/07, enacting clause stricken, did not pass 4/20/07) |
 -
NY
AB 3645
Asm. Raia

Would exclude from personal income taxation moneys paid by a taxpayer over the age of sixty-five for prescription drugs whose New York adjusted gross income is below or equal to $60,000. 
(Filed and sent to committee 1/26/07; resent to committee 5/7/07)

Tax
NY
AB 3683
Asm. Grannis
Would provide eligibility under the program for elderly pharmaceutical insurance coverage (EPIC) for otherwise covered persons who reside in nursing homes.
(Filed and sent to committee 1/26/07, enacting clause stricken, did not pass 4/20/07) |
S
NY
AB 3794
Asm. Grannis
Would require the Commissioner of Health Services to conduct a cost/benefit analysis of pharmaceutical advertising and promotional activities associated with the provision of prescription drugs to citizens in this state.
(Filed and sent to committee 1/29/07, enacting clause stricken, did not pass 4/20/07) |
Mkt
NY
AB 3804
Asm. Schimminger
SB 1286
Would establish a corporate Franchise Tax credit for co-payments for prescription drugs which are not collected by pharmacies pursuant to federal law or regulations.
(Filed and sent to committee 1/29/07)
Copay, Tax
NY
AB 3848
Asm. Gottfried
Would create the Prescription Drug Assistance Program to provide access to prescription drugs at reduced costs and establish the Prescription Drug Assistance Board.
(Filed and sent to committee 1/29/07)
D, S
NY
AB 4075
Asm. Ramos
Would provide that every insurance policy that provides coverage for prescription drugs shall insure that there is continuous coverage of a single source drug that is part of a prescribed therapy until such prescribed therapy is no longer medically necessary for the enrollee of such policy; defines single source drug.
(Filed and sent to committee 1/31/07)
Brand
NY
AB 4217
Asm. Lafayette
Would prohibit  price discrimination by manufacturers of prescription drugs in the price they offer drugs for sale to various purchasers or wholesalers; requires manufacturers to offer such drugs on the same terms they offer to their most favored purchasers; provides penalties for violation and exempts labor organizations from such provisions.
(Filed and sent to committee 1/31/07)
Price
NY
AB 4734
Asm. P. Rivera
SB 5294

Would allow the dispensing of a 3 month supply of a drug or controlled substance when used for a chronic condition.  Would prohibit insurance companies from reducing reimbursement or charging a higher deductible or copay for a 3 month supply.
(Filed and sent to committee 2/6/07)

Price

NY
AB 4814
Assm. Mayersohn
S 2667

Would require prescriptions to be electronically printed or handwritten in legible printing. Prohibits use of script letters in handwritten prescriptions.
(Filed and sent to committee 2/6/07)
Label
NY
AB 4883
Asm. Burling
Would make diversion and illegal possession of prescription medications and devices a 5th to 1st degree crime.
(Filed and sent to committee 2/8/07)
Safety
NY
AB 4914
Asm. Burling
Would lower copays in the EPIC program for certain participants.
(Filed and sent to committee 2/8/07; held for consideration in Aging 6/12/07)
Copay, S
NY
AB 5521
Asm. Cole
Would provide for annual cost of living adjustments to be made in the income eligibility levels for participation in the program for elderly pharmaceutical insurance coverage (EPIC) in accordance with adjustments made  for social security benefits.
(Filed and sent to committee 2/16/07; held for consideration in Aging 5/30/07)
S
NY
AB 5610
Asm. Kolb
 
 Would authorize the creation of a benefit evaluation commission and pharmaceutical fee schedule.
(Filed and sent to committee 2/20/07)
Price, Study

NY
AB 6100
Asm. Morelle
SB 3299
Sen. Lavalle

Would prohibit insurance companies from limiting the quantity of drugs dispensed per perscription and increase amount from 30 to 90 days. The sponsors claim "The limit on the quantity of prescription drugs to a 30 day supply causes patients to
pay additional co-payments to receive the quantity prescribed. Additional trips and co-payments to the pharmacists sometimes overburden the patient, especially elderly patients."
(Filed and sent to committee 3/2/07)
 -
NY
AB 6278
Assm. Benjamin
Would allow the creation of a drug guide for seniors regarding the drugs commonly used by people over 55 years of age.
(Filed and sent to committee 3/6/07; passed Assembly and sent to Senate 6/20/07)
CL

NY
AB 6341
Assm. Gottfried

SB 2642
 

Would regulate pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits, including requrement for a "trust" relationship with clients of the PBM, written reports on the terms and conditions of financial arrangements with pharmaceutical manufacturers and wholesalers and prohibiting the PBM substituting any drug for one originally prescribed, except with the prior consent of the prescriber or as specified by law.
(Filed and sent to committee 3/7/07; passed Assembly 6/6/07)
PBM
NY
AB 9399
Asm. Brodsky
 

 Would prohibit manufacturers and distributors of prescription drugs from deducting the costs of advertising such drugs to consumers from their corporate or personal income taxes.
(Filed and sent to committee 9/12/07)

 Mkt

NY
SB 27
AB 4531

Would prevent health insurers from denying reimbursements to insureds for using an unapproved or out of network pharmacy; would allow any willing pharmacy (AWP) provider to participate.
(Filed and sent to committee 1/3/07)

AWP
NY
SB 455
Sen. Golden
AB 8028
Would provide for the prescription drug reimportation protection program for the investigation of the sale of unsafe drugs including internet sales.
(Filed and sent to committee 1/3/07)
Internet
NY
SB 511
Sen. Maziarz
Would provide that an individual shall not become ineligible under the Elderly Pharmaceutical Indemnity Program (EPIC) due to an increase in Social Security benefits or a public or private pension.
(Filed and sent to committee 1/3/07, reported and committeed to Finance 4/23/07)
 S
NY
SB 582
Sen. Nozzolio
Would increase the income limits on the elderly pharmaceutical insurance coverage program (EPIC) to $42,000 for single and $65,000 for married couples.
(Filed and sent to committee 1/3/07)
 S
NY
SB 652
A 1279
Would all residential health care facilities to return and redistribute unused medication.
(Filed and sent to committee 1/5/07)
Reuse
NY
SB 1211
Would provide that no prescription for a controlled substance shall be on a prescription form which authorizes any other drug or controlled substance; provides that the total number of drugs, which may not exceed three, included on a single prescription form shall be indicated in a box on such form.
(Filed and sent to committee 1/17/07)
 E
NY
SB 1308
Asm. Stachowski
Would establishes in the department of health a controlled substances prescription tracking program; requires pharmacists to electronically submit all prescriptions of controlled substances into a computerized central data system; authorizes the program to charge a fee for data retrieval and maintenance.
(Filed and sent to committee 1/18/07)
 E
NY
SB 1441

Would create a temporary State commission to study and evaluate Medicaid reimbursement plans and rates for prescription drugs and potential cost-saving measures related thereto.
(Filed and sent to committee 1/19/07)

M, Study
NY
SB 1748
Sen. Sabini
Would require all pharmaceutical clinical trials and studies to be posted on website to provide public with full disclosure; provides definitions; requires the Commissioner of Health to collect and post, monitor the website for compliance and provide public service announcements; creates task force on clinical trials and studies.
(Filed and sent to committee 1/25/07)
Trials
NY
SB 1776
Sen. Golden

Would create the state pharmaceutical local choice program to require that prescription drug plans within health insurance policies permit insureds to purchase pharmaceuticals from and "willing" local pharmacies (AWP).
(Filed and sent to committee 1/25/07)

AWP
NY
SB 2005

Would  require manufacturers engaging in direct to consumer advertising to prescription drugs to clearly state the primary function of the prescription drug in such advertisement.
(Filed and sent to committee 1/30/07)

 Mkt
NY
SB 2009
Would require insurers to allow insures to obtain prescribed drugs and medical devices directly from a participating pharmacy where such insurer otherwise requires purchase of such drugs from a mail order pharmacy.
(Filed and sent to committee 1/30/07)
 Mail
NY
SB 2056
Sen. Defrancisco
Would prohibit the sale of information listed on prescriptions that identifies specific patients or persons legally authorized to issue a prescription; provides exceptions; provides violations enforced by commissioner of education; provides that violations result in $1000 civil penalty per violation.
(Filed and sent to committee 1/30/07)
 Mkt
NY
SB 2644
AB 5178
Would allow those eligible for social security disability insurance to be eligible for EPIC Rx program.
(Filed and sent to committee 2/8/07)
S
NY
SB 2968
Would exempt policies for use in health savings accounts pursuant to section 1201 of the Federal Medicare Prescription Drug, Improvement and Modernization Act of 2003 from certain coverage requirements.
(Filed and sent to committee 2/16/07; passed Senate and sent to Assembly 6/11/07)
HSA, MMA
NY
SB 2971
Sen. Maziarz
AB 7468

Would require pharmaceutical drug manufacturers and wholesalers to annually report, for disclosure to the general public, all of its gifts to health care practitioners that prescribe drugs when such gifts have a certain value.
(Filed and sent to committee 2/16/07; passed Assembly and sent to Senate 6/22/07)

 Mkt, Whole
NY
SB 2976
Would prohibit Medicaid's use of any prior approval or preferred drug list requirements for AIDS, HIV, infection or hepatitis C.
(Filed and sent to committee 2/16/07)
 M, PDL
NY
SB 3028
Sen. Seward
Would limit copayments for prescription drugs to no more than the retail price of such drug.
(Filed and sent to committee 2/20/07)
Copay, Price
NY
SB 3340
Sen. Krueger
Would define pharmaceutical benefits manager (PBM) as an entity that administers, develops formularies for, provides professional support for or performs utilization review for a health maintenance organization's, or an insurer's, pharmaceutical benefits; provides for disclosure of information on pharmaceutical benefits managers by HMOs and in health insurance contracts, including ownership.
(Filed and sent to committee 3/5/07)
PBM
NY
SB 3357
Sen. Kruger
Would requires a cost/benefit analysis of pharmaceutical advertising and promotional activities associated with the provision of prescription drugs to citizens in this state.
(Filed and sent to committee 3/5/07)
 
 Mkt

NC
SB 4

Would concern sheriffs access to Rx information.
(Filed 1/24/07)
Privacy
ND
HB 1244 
Would relates to confidentiality of pharmaceutical manufacturer rebates obtained by the public employees retirement system.
(Filed and sent to committee, did not pass House 1/29/07) |
Price
ND
HB 1256
Creates a prescription drug and device donation and repository program, including providing an appropriation.
(Filed 1/30/07; passed House ; passed Senate, 2/07; signed into law by governor 4/07)
Reuse
ND
HB 1366
Rep. Keiser

Would prohibit certain practices by pharmacy benefits managers and to provide a penalty.
(Filed; passed house 2/8/07; did not pass Senate, 1y-43n, 13/07) |

PBM
ND
HB 1455
Rep. Thoreson
Relates to the pedigree for wholesale drugs; relates to criminal history record checks.
(Filed 1/15/07; passed House  94y-0n, 2/13/07; passed Senate 46y-0n, 3/20/07; signed into law by governor 3/29/07)
Safety, Whole
ND
HCR 3038
Rep. Meyer

A non-binding concurrent resolution supporting the North Dakota Congressional Delegation's efforts to make prescription drugs more affordable and urging Congress to take the necessary actions to make prescription drugs more affordable for all Americans.
(Filed 1/26/07, passed House 2/15/07; failed to be adopted in Senate 3/22/07) |

Price
ND
SCR 4006
Non-binding resolution ould urge Congress to require the United States Department of Veterans' Affairs assume all health care and pharmaceutical needs of veterans in state veterans homes.
(Filed, passed Senate 1/19/07; passed House 3/22/07) |
-
OH
HB 39
Rep. Skindell

Would require manufacturers and labelers of dangerous drugs to disclose to the Director of Health the value, nature, and purpose of certain gifts, fees, payments, subsidies, and other economic benefits they provide in connection with pharmaceutical detailing, marketing, or promotion.
(Filed and sent to committee 2/21/07; no further action before end of session) |

 Mkt
OH
HB 283
Rep. Webster
 Would allow a pharmacy school to accept "dangerous drugs" or expired products for instructional purposes only.
(Filed and sent to committee 9/11/07; no further action before end of session) |
 -
OK
HB 1084; new#
Rep. Wesselhoft
Creates the Oklahoma Pharmacy Connection Program, including the feasibility of implementing a computer software program that would link eligible persons with appropriate manufacturer-sponsored prescription drug assistance programs and a review and assessment of pharmaceutical discount or insurance programs.
(Filed 1/07; passed House; passed Senatte; signed into law by governor as chapter 98, 5/30/07) | 
CL, D
OK
HB 1330
Rep. Martin
Would add mental health drugs to the preferred drug list that cannot be substituted.
(Filed 2/6/07; held, did not pass committee 6/29/07) |
PDL
OK
HB 1899
Rep. Hamilton

Would provide for the Board of Pharmacy to promulgate rules allowing pharmacies to sell discounted pharmaceuticals to certain persons; provides for certain information to be displayed on a certain website.
(Filed 2/6/07; held, did not pass committee 6/29/07) |

D
OK
HB 1918
Would provide for the Board of Pharmacy to establish a procedure to purchase certain pharmaceuticals; provides penalty for the sale of counterfeit pharmaceuticals.
(Filed 1/22/07; held, did not pass committee 6/29/07) |
Whole
OK
HB 1938
Rep. McMullen
Would require the registration of pharmaceutical sales representatives with a state commission; specifies fees; provides for registration forms, reports and termination procedures.
(Filed 1/22/07; held, did not pass committee 6/29/07) |
Mkt
OK
HB 1991
Would provide for transfer of unused drugs from certain facilities.
(Filed, passed House 2/22/07; passed Senate 45y-0n, 4/9/07)
Reuse
OK
SB 404
Sen. Adelson
Would create the Prescription Drug Reimportation Act; authorizes certain pharmacists and wholesale drug distributors to procure and import specified prescription drugs; provides for certification of specified prescription drugs; prohibits importation of drugs without certain certification; specifies list of entities authorized to import certain drugs; provides for violation of provision.
(Filed 1/12/07; did not pass committee before end of session) |
Imp, Whole
OK
SB 666
Sen. Leftwich
Would create the Prescription Drug Reimportation Act; authorizes certain pharmacists and wholesale drug distributors to procure and import specified prescription drugs; provides for certification of specified prescription drugs; prohibits importation of drugs without certain certification; specifies list of entities authorized to import certain drugs.
(Filed 1/18/07; did not pass committee before end of session) |
Imp, Whole
OK
SB 667

Would direct certain information to be placed on a prescription label in certain circumstance; requires certain persons to provide specified information; provides exceptions.
(Filed 1/18/07; held, did not pass committee 6/29/07) |

Label
OK
SB 835
Sen. Sykes
Would create the Transplant Patient Prescription Drug Safety Act and prohibit certain putting transplant related prescription drugs on any prior authorization or step therapy process.
(Filed 1/22/07; did not pass committee by end of session) |
M, MMA, PDL, Safety
OK
SB 1064
Sen. Lerblance

Would relate to prescriptions; establishes certain prescription requirement.
(Filed 1/22/07; held, did not pass committee 6/29/07) |

Label
OK
HCR 1012
Would create the Task Force on Pharmacy Benefit Management Services; provides for membership.
(Filed 1/29/07; passed Senate, sent to House; no further action before end of session)|
PBM
OK
HJR 1018
Would creates the Task Force on Drug Importation.
(Filed 1/22/07; no further action before end of session) |
Imp, Study
OR
HB 2003
Rep. Roblan
Would allow all residents into the OR Prescription Drug Program.
(Filed 3/8/07; did not pass committee 6/28/07) |
D
OR
HB 2216,
SB 362
Gov. Kulongoski
Sen. Morrissette
Would expand the list of entities that may participate in Oregon Prescription Drug Program to include residents who do not have prescription drug coverage, private sector employers and Multiple employer welfare arrangement (MEWA) groups.
(Filed 1/11/07; did not pass committee 6/28/07) |
D
OR
HB 2221
Gov. Kulongoski
 
Establishes licensing requirements for persons marketing, offering for sale or selling, promoting, distributing or administering discount medical plans; prohibits operation of discount medical plan organizations, including discount prescription drug plans, without license and without contract or agreement with service provider or service provider network.
(Filed 1/11/07; passed House 59y-0n, 4/10/07; passed Senatesigned into law by governor as Chapter 272, 6/1/07) |
D
OR
HB 2523
Rep. Tomei
Would require pharmaceutical manufacturing companies to annually disclose to Department of Justice economic benefits of $25 and up provided in conjunction with marketing of prescription drugs; directs department to report disclosures; exempts free samples, clinical trials and medical student aid; authorizes a civil penalty up to $10,000 for each violation of disclosure of required information; establishes Pharmaceutical Marketing Disclosure Fund.
(Filed 1/30/07; did not pass committee 6/28/07) |
Mkt
OR
HB 2648
Rep. Greenlick
Would prohibit pharmaceutical manufacturers from providing gifts to prescribers in conjunction with marketing their products.  Imposes civil penalties (Pharmaceutical Marketing Penalty Fund) which would be used to appropriate moneys for the administration and enforcement of the act.
(Filed 2/8/07; did not pass committee 6/28/07) |
Mkt
OR
SB 34
Comm. on Public Health
 Would require State Board of Pharmacy to establish electronic database for information reported by pharmacies regarding dispensing of certain controlled substances; restricts access to and limits use of information in database; creates Electronic Prescription Drug Database Advisory Commission.
(Filed 1/11/07; passed Senate 3/8/07; passed House amended; did not pass final action 6/28/07)|
E
OR
SB 160
Gov. Kulongoski
Would permit the Department of Human Services to require prescribing practitioner to request prior authorization of payment for medically appropriate drugs not listed on Practitioner-Managed Prescription Drug Plan drug list.
(Filed  1/15/07; did not pass committees 6/28/07) |
M, PDL
OR
SB 715
Comm. on Health Policy
Would allow a pharmacy to repackage prescription drugs when requested to do so by patient if  it meets certain labeling requirements
(Filed 3/5/07; did not pass committee 6/28/07) |
Label
PA
HB 185
HB 186
Provides for prescription drug redistribution within health care and State correctional facilities.  HB 186 would affect accepting and dispensing donated cancer drugs.
(Filed and sent to committee 2/1/07)
Reuse
PA
HR 15
Would urge the U.S. Congress and the Department of Health and Human Services to establish and maintain a comprehensive national registry for clinical drug trial results, requiring that all drug trial results, both positive and negative, be disclosed.
(Filed and sent to committee 2/1/07)
Trials
PA
HB 536

Would further define income for purposes for pharmaceutical assistance for the elderly.
(Filed and sent to committee 2/23/07)

 D, S
PA
HB 643
Would establish the Pharmaceutical Cost Management Council. Provides for cost containment and study of generic substitution and prescribing older, less costly drugs instead of newer, more expensive drugs.  Would study a shared preferred drug list for use by the public employee insurance agency, the Medicaid program and other state payors and private insurers.
(Filed and sent to committee 3/6/07)
 
 Study, Generic, Brand
PA
HB 1811

 Would make slight changes to PACENET program eligibility.
(Filed and sent to committee 9/4/07)

 S
PA
HB 2073
Would require pharmacies to have receptacles to accept unused prescriptions for proper disposal.
(Filed 11/26/07) |
 -, Reuse
PA
SB 260

 Would prohibit an insurer from requiring an insured to obtain drugs from a mail-order pharmacy as a condition of obtaining payment for prescription drugs. 
(Filed and sent to committee 3/8/07)

 Mail
PA
SB 339
Would define clinical trial and pharmaceutical drug and for drug manufacturer clinical trials reporting.
(Filed and sent to committee 3/12/07)
 Trial
PA
SB 638
 Would establishe the Cancer Drug Repository Program for accepting donated cancer drugs and dispensing cancer drugs.
(Filed and sent to committee 3/21/07, laid on table (died)).|
 Reuse
PA
SB 1094
 Would allow electronic prescriptions.
(Filed and sent to committee 9/17/07)
 E
RI
H 5193
Rep. Picard
Would require that mail order pharmaceuticals be signed for by a person at least 17 years old.
(Filed 1/24/07, held in committee for study 3/7/07; did not pass by end of regular session 7/2/07*) |
Mail
RI
H 5458
Rep. McNamara
Would eliminate limits on prescriptions of schedule II controlled substances of a maximum of a 30 day supply and a maximum of 250 dosage units.
(Filed 2/27/07, held in committee for study 3/7/07; did not pass by end of regular session 7/2/07*) |
Safety
RI
H 5822,
S 789
Rep. Sullivan
Would coordinate benefits between the elderly pharmaceutical assistance program and Medicare Part D prescription drug plan. It would require the general assembly to fund the program at levels at least equal to the amount appropriated in fiscal year 2007.
(Filed 3/1/07; held in committee 3/07; did not pass by end of regular session 7/2/07*) |
MMA, S
RI
H 5850
Reo. Sullivan
Extended to April 2007 the date on which the Department of Health is required to implement a statewide program consistent with the Utilization of Unused Prescription Drugs Act. This act would also require the state to notify nursing home residents of this statewide program, which allows "recycling" of unused prescriptions.
(Filed 3/1/07; passed House 4/25/07; passed Senate 6/29/07; became law without governor's signature as Chapter 315, 7/7/07) |
Reuse

RI
H 5955
Rep. Wasylyk

Would disclose information regarding clinical trials of prescription drugs to the public, physicians, researchers and state policy makers and administrators.
(Filed  3/1/07; held in committee 3/07; did not pass by end of regular session 7/2/07*) |
Trial
RI
H 6187
Rep. Mumford
Authorizes and directs Medicaid to impose co-payments for prescription drugs in the amount of $1.00 for generic drug prescriptions and $3.00 for brand name drug prescriptions as part of the medical care benefits to eligible beneficiaries.
(Filed; passed House 4/24/07; passed Senatesigned into law by governor 7/03/2007)
Brand, Copay, Generic, M
RI
S 251
Sen. Levesque
Would allow pharmacies to provide a list of 20 prescribed drugs in electronic format to the Department of Health with current selling prices.  The list would then be posted on a state website accessible to the general public for pricing information.
(Filed  2/7/07; held in committee 2/07, 6/29/07)
Price
RI
S 593
Sen. Moura

Would revise and expand the Rhode Island Best Rx Program to provide discount prescription drug assistance to the uninsured, defined as any one over age 60, on SSDI; also raising the  maximum income for those under age 60 from 200% FPL to 300% FPL. Also deletes the previous $30 annual enrollment fee.
(Filed 2/15/07; passed Senate 6/13/07; passed House 6/22/07; vetoed by governor 7/3/07, veto overriden 10/30/07)

D
RI
S 653
Sen. Pichardo

Would allow prescription privacy and prohibit patient identifying information from being transferred.  Also addressed the ethical marketing of prescriptions.
(Filed  2/15/07; held in committee 2/07; did not pass by end of regular session 7/2/07*) |

Mkt, Privacy
SC
HB 3198
Rep. White
Would create the Cancer Drug Donation Program Act; establishes this program for the donation of cancer drugs to certain patients who do not qualify for Medicaid or any state funded prescription drug program; establishes immunity from civil and criminal liability and from professional disciplinary action.
(Filed and sent to committee 1/9/07; did not pass committee by end of '07-'08 sessions 6/5/08) |
Reuse
SC
HB 3414
Rep. Hosey
Would provide that any licensed health care practitioner must write prescriptions in legible writing in terms that can be understood by the person for whom the prescription is written.
(Filed and sent to committee 2/1/07; did not pass committee by end of '07-'08 sessions 6/5/08) |
Label

SC
HB 3774,
HB 4028
Rep. Mitchell

Would authorize and establish the procedures for electronic prescription processing, including contents of prescriptions, acceptable methods of electronic prescription transmission, criteria and safeguards for the electronic equipment utilized to electronically transmit these prescriptions, patient confidentiality and sanctions for violations.
(Filed 5/2/07; H 4028 passed House 5/12/07; did not pass committee by end of '07-'08 sessions 6/5/08) |
E, Privacy

SC
SB 206
Sen. Cromer

Would provide for the licensing and regulation of pharmacy benefit managers (PBMs), including requirements for a certificate of authority  and annual reporting. Also requires PBMs to disclose agreements with a pharmaceutical manufacturer to favor the manufacturer's products over a competitor's products or to place the manufacturer's drug on the PBM's preferred list or formulary or to switch the drug prescribed with a drug agreed to by the PBM and the manufacturer; agreements with a pharmaceutical manufacturer to share manufacturer rebates and discounts or other economic benefits with the PBM; agreements to bill health plans for prescription drugs at a cost higher than the PBM pays the pharmacy and agreements to share revenue with a mail order or internet pharmacy company.  Requires that if a substitute drug costs more than the prescribed drug, the substitution must be made for medical reasons that benefit the covered individual. Customers may audit PBM records..
(Filed 12/13/06; did not pass committee by end of '07-'08 sessions 6/5/08) |
Internet, Mail, PBM
SC
SB 528
Sen. Cromer
Would establish the requirements for transmitting a prescription electronically; maintains confidentiality of information; prohibits pharmacist or pharmacy from providing electronic devices to practitioners or facilities as an incentive to refer patients.
(Filed 3/6/07; did not pass committee by end of '07-'08 sessions 6/5/08) |
E, Privacy
SD
HB 1031
Health & Human Services
Provides for the regulation of telepharmacy; including licensing, staffing, annual fee up to $250 and use of remote pharmacy auotmated dispensing machinces.
(Filed 1/9/07, passed House 65y-4n, passed Senate 31y-4n, 2/20/07; signed into law by governor 3/1/07)
E
SD
SB 1150
Would revise provisions relating to deceptive trade practices; relates to discount cards from pharmacies for prescription drug purchases; requires such cards to plainly state that they are not insurance.
(Filed 1/24/07, and sent to Secretary of State's office 3/1/07)
 
-
SD
HB 1155
Rep. Van Etten
Revises provisions concerning wholesale drug distributors, including licensing and requiring "pedigree records," a document or electronic file containing information that records each wholesale distribution of any given prescription drug outside the normal distribution channels; defines violations as misdemenors or felonies.
(Filed 1/29/07, passed House 68y-1n, 2/13/07; passed Senate 33y-0n, 2/28/07; signed into law by governor 3/26/07)
Safety, Whole
TN
HB 12,
SB 68

Rep. Curtiss
Would require the commissioner of finance and administration to enter into discussions with the member states of the I- SAVE RX program and to either participate in that program or establish a separate state program providing cost savings for prescriptions purchased internationally.
(Filed 1/20/07; HB 12 failed to pass House 4/25/07; SB 68 in committees 6/11/07)
Imp

TN
HB 121,
SB 442
Rep. BeBerry

Requires informed consent before interchanging or substituting for a prescribed anti-epileptic drug; violation is a misdemeanor.
(Filed 1/30/07; HB 121 passed House 95y-1n, 4/30/07; passed Senate 5/14/07; signed into law by governor 6/7/07)
Brand, PDL
TN
HB 364
Rep. Rowland
SB 887
Sen. Ketron
Would allow prescribers to electronically note that a brand name drug is to be issued to a patient rather than a generic and clarifies that electronic signatures may be used on electronic and facsimile prescription orders.
(Filed 2/8/07, 4/4/07; did not pass committee by end of 2007 session*)
E, Brand, Generic

TN
HB 586, HB 2261
SB 775, SB 2227
Rep. DuBois,
Rep. Odom

Makes it a criminal offense to divert TennCare prescriptions as well as failure to disclose to a doctor that a person has received a prescription for a controlled substance within 30 days when obtaining another prescription for a controlled substance.
(Filed 2/21/07; HB 2261 passed House 94y-0n, 5/24/07; passed Senatesigned into law by governor as Public Chapter 418, 6/19/07) |
M, Safety
TN
HB 821,
SB 297

Rep. Hood
Would establish a system that requires prescribers to use official prescription forms.
(Filed 2/21/07; did not pass committee by end of 2007 session*)
Label
TN
HB 1190
Rep. Shepard
SB 1197
Sen. McNally
Would clarify duties of wholesalers and distributors of pharmaceutical products.
(Filed  2/14/07, 5/15/07; did not pass committee by end of 2007 session*)
Whole
TN
HB 1343
Rep. Overby
SB 1112 - final text
Sen. McNally

Clarifies the duties of pharmacy benefit management companies (PBMs) and mail order pharmacies, including providing protections for retail pharmacies during any audit by PBMs or by the state, requiring 30-days advance notice, rights of appeals and prohibiting extrapolation of particiular transactions. Also requires that reimbursement tables for payment by PBMs be updated every three days.  Effective date 7/1/07.
(Filed 2/15/07; SB 1112 passed Senate; passed House; signed into law by governor as Public Chapter 224, 6/1/07) |

Audit, Mail, PBM
TN
HB 2167
Rep. Briley
SB 1389
Sen. Haynes

Would allow a patient to file a grievance related to a change to the insurer's formulary within 45, rather than 60 days; increases the time period to 15 calendar days, rather than 10 days, for the insurer to be able to file the complaint and retain the right to continue the drug until the grievance process is completed; specifies that the grievance procedure is not applicable to any state administered insurance.
(Filed 2/12/07; did not pass committee by end of 2007 session*)

Brand, PDL
TN
HB 2234,
SB 2172
Rep. DeBerry,
Sen. Kyle

Would change the laws on disclosure of information from the controlled substances monitoring program, clarifying that health professionals are prohibiting from disclosing beyond the patient or dispensers identified in the database information.
(Filed  2/15/07 HB 2234 passed House 4/30/07; passed Senate 28y-0n, 6/6/07; signed into law by governor as Public Chapter 498,  6/27/07) |

E, Monitor, Privacy
TN
HB 2249,
SB 2192

Sen. Kyle
Removes provision whereby controlled substance database information is available to TN Bureau of Investigation criminal enforcement personnel actively engaged in analysis of controlled substances prescription information as a part of their assigned duties and responsibilities related directly to TennCare.
(Filed 2/15/07; SB 2192 passed Senate 29y-0n, 6/6/07; passed House 94y-1n, 6/7/07; signed into law by governor 6/25/07) |
M, Monitor, Privacy
TN
HB 2276, HB 2278
SB 2210, SB 2212
Rep. Odem
Among other things, would require each discount drug plan to provide information regarding membership cancellation.  Would also require the board of pharmacy to report when fines are collected for violation of the TennCare legend drug provisions.
(Filed 2/15/07; did not pass committee by end of 2007 session*)
Card, D, M
TN
SJR 142
Sen. Finney
Would urge Congress and appropriate federal agencies to recognize problems caused by direct-to- consumer advertising by pharmaceutical companies and to limit it or ban it altogether.
(Filed 5/1/07; passed Senate 23y-0n, 4/5/07; did not pass House by end of 2007 session) |
 Mkt
TX
HB 533
Rep. Dukes
Would create a prescription drug retail price registry and require disclosure of a list of prescription drug retail prices for the 150 most commonly used medications, updated at least weekly.
(Filed and sent to committee 1/10/07; did not pass by end of regular session 5/16/07) |
Price
TX
HB 948
Rep. Davis
Establishes requirements for prescription drug retail labels, including cautionary statements, be printed in visible type at least 8-point size, to avoid potential patient error.  Effective September 1, 2007.
(Filed  1/30/07; passed House; passed Senatesigned into law by governor 6/16/07) |
Label, Safety

TX
HB 1369
Rep. Macias

Would change procedure for filing prescriptions for nursing home residents.
(Filed and sent to committee 2/19/07; did not pass by end of regular session 5/16/07) |

 -
TX
HB 1613
Rep. Gattis
Would amend the delivery of prescription drugs for certain state health plans by mail order and provide for a penalty.
(Filed and sent to committee 2/16/07; passed House 5/10/07; did not pass by end of regular session 5/16/07) |
M, Mail
TX
HB 1676,
SB 1223
Rep. Delisi,
Sen Van de Putte

Requires the TX Attorney General to develop a public awareness campagn to educate consumers about solicitations by email or Internet, including information on distinguishing reputable pharmacies from unlicensed or fraudulent sales. The campaign may use brochures, advertisements and similar outreach and may accept grants and donations to fund the effort.
(Filed 2/20/07; HB 1676 passed House 145y-0n, 3/28/07; passed Senate 4/26/07; signed into law by governor 5/14/07) |

Mkt, Internet
TX
HB 1891
Rep. Goolsby

Would regulate patient assistance programs by requiring a pharmaceutical company that does business in TX and offers PAP free or discounted drugs to "affiix a symbol" that indicates the drug is not a sample, includes the patient's name and creates a log of all PAP shipments to physicians instead of to patients.
(Filed 2/23/07; did not pass House by end of regular session 5/16/07) |

CL, D
TX
HB 1953
Rep. Leibowitz
Relates to the labeling requirements for drugs dispensed by pharmacists.
(Filed and sent to committee 4/10/07; did not pass House by end of regular session 5/16/07) |
Label

TX
HB 1974
Rep. Miller

Would require regulation of pharmacy benefit managers (PBMs)
(Filed and sent to committee 2/26/07; withdrawn; did not pass House by end of regular session 3/28/07, 5/16/07) |
PBM
TX
HB 2037
Rep. Laubenberg

Would regulate the use of automated pharmacy systems.
(Filed and sent to committee 3/1/07; did not pass House by end of regular session 3/28/07, 5/16/07) |

 -
TX
HB 2067
Rep. Martinez
 Would prohibit the limiting of prescriptions dispensed to a Medicaid patient to less than 4 per month.
(Filed and sent to committee, left pending; did not pass House by end of regular session 3/28/07, 5/16/07) |
 M
TX
HB 2316
Rep. Truitt

Would regulate wholesale pharmacy distributors.
(Filed and sent to committee, left pending; did not pass House by end of regular session 4/18/07, 5/16/07) |

Whole
TX
HB 2920
Rep. Miller
Would mandate insurance companies to provide 90 days medication coverage of any prescription after changing the drug formulary.
(Filed and sent to committee, 3/15/07; did not pass House by end of regular session 5/16/07) |
Brand, PDL
TX
HB 3064
Rep. Delisi
Requires registration and regulation of certain health and prescription drug discount card programs, to provide consumer protections.
(Filed 3/7/07; passed House; passed Senate 5/25/07; signed into law by governor 6/15/07) |
Card, D
TX
HB 3078
Rep. Delisi
SB 1896
Sen. Lucio

Would allow a pharmacist in a prison setting to redistribute non-controlled substances under certain conditions.
(Filed 3/8/07; tabled; did not pass House by end of regular session 5/16/07) |

Reuse

TX
HB 3280
Rep. Isett

Would regulate the treatment of pharmaceutical services provided through specialty and mail order pharmacy services operated under contracts between governmental entities and pharmacy benefit managers.
(Filed and sent to committee 3/20/07; did not pass House by end of regular session 5/16/07) |
Mail, PBM, -
TX
HB 3454
Rep. Callegari
 
Would regulate pharmacy benefit manager contracts by prohibiting PBMs from charging brand or generic more than the lowest price available to the PBM and reqiring pass-through of rebates.
(Filed 3/8/07; did not pass House by end of regular session 5/16/07) |
PBM

TX
HB 3850
Rep. Taylor
SB 1582
Sen. Van de Putte

Would regulate the payment by pharmacy benefit managers (PBMs) of certain clean claims.
(Filed and sent to committee 4/24/07; SB 1582 passed Senate 31y-0n, 5/3/07; did not pass House by end of regular session 5/16/07) |
PBM
TX
HB 3927
Rep. Davis
Would authorize use of limited number of contracted pharmacies for goverment employee plans for "cost effectiveness."
(Filed and sent to committee 3/22/07; did not pass House by end of regular session 5/16/07) |
 -

TX
SB 39
Sen. Nelson

Would create a cancer drug donation program, allowing a person to donate a cancer drug or supplies at a physician’s office, pharmacy or health care facility that elects to participate in the program. 
(Filed 12/06; did not pass by end of regular session 5/16/07) |
Reuse
TX
SB 414
Sen. Lucio
Would require pharmaceutical companies and marketers to report gifts valued at $75 or more on an annual basis to the Department of State Health Services and require that agency to post all such reports online. Would include an administrative penalty of up to $10,000 for each failure to report.  Effective date January 1, 2009.
(Filed 2/21/07; did not pass by end of regular session 3/9/07; 5/16/07) |
Mkt, Whole
TX
SB 809
Sen. Janek

Would regulate automated pharmacy systems.
(Filed 2/22/07; passed Senate 4/19/07; did not pass House by end of regular session 5/16/07) |

-
TX
SB 943
Sen. Janek
Requires licenses and regulation of pharmaceutical wholesale distributors and closes loopholes "in order to better protect Texas drug consumers;" requiring the state to conduct a physical inspection of the place of business at the address provided by applicants.
(Filed  4/24/07; passed Senate 5/17/07; passed House 5/21/07; signed into law by governor 6/15/07) |
Safety, Whole
TX
SB 1620
Sen. Van de Putte
Would establish requirements for confidentiality of prescription information, including that records "containing patient-identifiable and prescriber-identifiable data may not be licensed, transferred, used, or sold by any pharmacy benefits manager, insurance company, electronic transmission intermediary, or retail, mail order, or Internet pharmacy or other similar entity for any commercial purpose except for the limited purposes of pharmacy reimbursement" and medical treatment; violations are classified as unfair or deceptive trade practices. Effective date 9/1/07.
(Filed and sent to committee 3/21/07; passed Senate 31y-0n, 5/3/07; did not pass House by end of regular session 5/16/07) |
Privacy
TX
SB 1834
Sen. Hegar

Relates to treatment of pharmaceutical services provided through specialty and mail order pharmacy services operated under contracts between governmental entities and pharmacy benefit managers.
(Filed 3/9/07; SB 1834 passed Senate 31y-0n, 5/1/07;  did not pass House by end of regular session 5/16/07) |
 

Mail, PBM
TX
SB 1896
Sen. Lucio
 
For the existing Texas Drug Donation Program allowing redistribution/re-prescribing of certain drugs, authorizes a licensed health care professional in a penal institution to return unusued Rx to a pharmacy.
(Filed 3/9/07; passed House; passed Senatesigned into law by governor 6/15/07) |
Reuse
TX
HCR 35
Rep. Rodriguez
Non-binding resolution urges the United States Congress to enact legislation to eliminate the 24-month Medicare waiting period for participants in Social Security Disability Insurance, making them eligible for Medicare Part D coverage.
(Filed 1/18/07; passed House; passed Senate 5/22/07; signed into law by governor 6/15/07) |
MMA

TX
HR 470
SR 285
Rep. Hopson,
Sen. Van de Putte

Non-binding resolution recognizes "Texas Pharmacy Day at the Dome" as February 21, 2007, on behalf of the "coalition provides important information about the pharmaceutical industry to its many members."
(Filed, adopted by Houseadopted by Senate; reported as enrolled 2/21/07; 2/26/07) |

-
TX
HR 479
Rep. Dukes
Non-binding resolution honors Montel Williams for "performing an important service in his role as national spokesperson for the Partnership for Prescription Assistance" which provides a "convenient and effective means" to obtain information about hundreds of public and private prescription programs, including Medicare, Medicaid and industry-sponsored programs.
(Filed, adopted by House 2/20/07; reported as enrolled 2/22/07) |
Brand, CL
TX
SR 234
Sen. Ellis

Non-binding resolution commends the Partnership for Prescription Assistance for providing patients access to medicines.
(Filed and passed Senate 2/20/07; reported as enrolled 2/22/07) |

Brand, CL
UT
HB 433
Rep. Last
Would relate to drug pedigree amendments, affecting safety of wholesale transactions.
(Filed 1/27/07; did not pass committee by end of regular session 2/16/07) |
Whole
UT
SB 42
Sen. Christensen
 
Allows use of a Preferred Prescription Drug List in Medicaid, which “may include placing some drugs on a preferred drug list to the extent determined appropriate by the department” and repeals 2003 language restricting PDLs.  Final version provides a blanket exemption for psychotropic or anti-psychotic drugs and allows prescribers to override restrictions in cases of "medical necessity" when documented in the patient's medical file and by handwriting on the prescription.
(Filed 12/26/06; passed Senate 28y-10n, 1/26/07; passed House 70y-1n, 2/6/07; signed into law by governor as Chapter 385, 3/20/07)
Brand, Bulk, M, PDL
UT
SB 146
Sen. Knudson
Would require pharmacies that do business as class B or Class D pharmacies over the Internet to meet national standards for Verified Internet Pharmacy Practices..
(Filed and passed committee; did not pass by end of regular session 3/1/07) |
E, Internet
VT
H 92
Rep. Chen
Would require confidentiality of patient prescription records and prevent the use of this information for commercial purposes, intended to protect patients and health professionals and to prevent it being "used to target pharmaceutical marketing and gifts toward physicians who prescribe the most expensive drugs for their patients."

(Filed and sent to committee 1/23/07; did not pass by end of session*)

Privacy
VT
H 344
Rep. Obuchowski
Would establish the Vermont prescription drug fair pricing program to regulate the price of prescription drugs sold in Vermont and to direct the retirement boards to divest the funds of the state employees’, teachers’, and municipal employees’ retirement systems of all interests in pharmaceutical companies.

(Filed and sent to committee 2/21/07; did not pass by end of session*)

Price
VT
H 376,
S 84
Rep. Koch,
Sen. Ciummings
Would require a health plan to pay promptly, by electronic funds transfer within eight days, any prescription drug claim submitted electronically.

(Filed and sent to committee 2/21/07; did not pass by end of session*)

E

VT
H 491,
S 87
Rep. Morrissey

Would give consumers notice of their right to buy prescriptions from retail pharmacies at the same co-payment as from mail-order pharmacies.
(Filed and sent to committees, 2/12/07; 3/1/07; did not pass by end of session*)
Mail, PBM, Price
VT
S 115
S. Finance Comm.
Increases "transparency of prescription drug pricing and information" by limiting "fraudulent" advertising of prescription drugs to consumers and health care professionals, requiring notice to clients by pharmacy benefit managers that certain types of contracts are available, expanding the Medicaid preferred drug list, establishing an evidence-based education program, providing additional pricing information including "AMP" and "Best Price," to the Medicaid program from drug manufacturers and requiring disclosure of education programs funded by drug manufacturers.   Also establishes regulation of PBMs including requiring that all financial and utilization information requested by a health insurer be provided, disclose the costs and financial arrangements with any formulary management, drug substitution including rebate and discount agreements.  Such disclosures may be defined as confidential and not subject to court inquiry.
    Includes a "plan to inform residents of the availability of health services and 340B prescription prices through federally qualified health centers, aimed at Medicaid, state employees, corrections, workers comp and any other public programs; also authorizes a joint pharmaceuticals purchasing consortium. Amended to add restrictions on "prescription information containing prescriber-identifiable data."

(Filed 2/23/07; amended 3/20/07; passed Senate 28y-1n, 4/4/07; passed House 89y-44n, 5/4/07; signed into law by governor as Chapter 80, 6/9/07)

NEWS UPDATE: VT: Companies sue state over prescription drug law By Rutland Herald, 8/80/07.  Three data-collection companies sued the state of Vermont Wednesday over a provision in the new prescription drug law that would conceal from public view what drugs doctors are prescribing to their patients.

340B, Bulk, Disclose, Generic, M, Mkt, PBM, PDL, Price, Privacy
VT
S 140
Sen. Lunge

Would ensure patient prescription records are confidential and prevent use for commercial purposes.
(Filed 2/26/07; did not pass by end of session; see S 115 signed law above)

Privacy, Mkt
VA
HB 945,
HB 1954,
Del. Morgan
Would establish requirements for regulation and registration of pharmacy benefits managers.  Upon request by purchasers, would require disclosure of  "all rebates, administrative fees, detailing payments, educational payments, and other retrospective discounts that the pharmacy benefits manager estimates it would receive"  from pharmaceutical manufacturers or labelers.  Would require pass-through of such rebates.

(Filed 1/10/07; HB 1954 did not pass committee by end of regular session 2/6/07; 2/24/07) |

PBM
VA
HB 2735
Del. Englin
Authorizes any city, town or locality to participate in the National Association of Counties (NACo) Prescription Drug Discount Program.

(Filed 1/10/07; passed House 51y-47n, 2/6/07; passed Senate 39y-0n, 2/16; signed into law by governor as Chapter 330, 3/13/07)

D
VA
HB 2810
Del. Sickles
Would establish a tax credit for all Rx expenses incurred by Medicare enrollees during the Medicare Part D prescription drug coverage gap period, with excess credit (above tax obligation) able to be carried over for five future years.
(Filed 1/10/07; did not pass committee by end of regular session 2/6/07; 2/24/07) |
MMA, S, Tax
VA
HJR 699
Del. J. Scott
Resolution would direct the Joint Commission on Health Care to study the accuracy of expiration or discard dates on prescription drugs; claiming that over 90% of more than 100 prescription and over-the-counter drugs tested by an FDA study "were safe and effective up to 15 years past their expiration dates," and authorizing the Commission to "evaluate the feasibility of extending such discard dates."

(Filed 1/10/07; did not pass committee by end of regular session 2/6/07; 2/24/07) |

Lab, Price, Study
VA
SB 954
Del. Quale
Would provide that the Department for the Aging may use any income tax refund contributions received for providing Medicare Part D counseling.
(Filed 1/9/07; passed Senate 40y-0n, 1/29/07; passed House 95y-0n, 2/14/07; sent to governor 03/20/07, Approved by governor-Chapter 601 (effective 7/1/07)).
MMA, Tax
VA
SB 1084

Would regulate pharmacy benefits management.
(Filed, Senate concurred in House substitute 2/22/07)

PBM
WA 
HB 1095,
SB 5091
Rep. Barlow,
Sen. Fairley
Authorizes, effective July 1, 2007, WA Medicaid to continue to offer Medicare part D prescription drug copayment coverage to dual eligible medical assistance and medically needy beneficiaries; subject to available 100% state funds.
(Filed 1/10/07; HB 1095 passed House, passed Senatesigned into law by governor as Chapter 3, 2/3/07) |
M, MMA, S
WA
HB 1348
Rep. Schual-Berke
Would regulate prescription drug practices by pharmacy benefit managers.
(Filed and sent to committee 1/17/07; did not pass by end of session 4/22/07) |
PBM
WA
HB 1356,
SB 5565
Rep. Cody
Would authorize purchase and require availability of brand name drugs when cost-effective or less expensive, for all state purchased health care programs.
(Filed 1/17/07; did not pass by end of session 4/22/07) |
Brand, Price
WA
HB 1553
Would establish a controlled substances prescription monitoring program.
(Filed and sent to committee 1/22/07; did not pass by end of session 4/22/07) |
E, Monitor
WA
HB 1704
SB 5605
Rep. Schual-Berke
Would require health care insurers to have open pharmacy networks, known as "any willing pharmacy," offering contractual agreements to all pharmacies willing to meet applicable terms and conditions.  Would ban imposing a extra copay, deductible, coinsurance, or prescription quantity limit upon a beneficiary that is not imposed upon all beneficiaries in the plan.
(Filed and sent to committee 1/25/07; did not pass by end of session 4/22/07) |
AWP
WA
HB 1786
 
Would provide a business and occupation tax deduction for the sale of certain prescription drugs.  HB 1786 specifies use for cancer treatment.
(Filed and sent to committee 1/17/07l did not pass by end of session) |
Tax

WA
HB 1826
SB 5699
Rep. Seaquist

Requires health insurers, including private insurers, group health plans, service benefit plans, managed care organizations, pharmacy benefit managers, or other parties that are, by statute, contract, or agreement, legally responsible for payment of a claim for a health care item or service, as a condition of doing business in Washington, to increase their effort to share information with the department.
(Filed and sent to committee 1/30/07; passed House 3/10/07; passed Senate; signed into law by governor as Chapter  2007-179, 4/21/07) |
PBM
WA
H 1891
 
Provides a business and occupation tax deduction for amounts received by physicians or clinics for drugs for infusion or injection by licensed physicians or their agents.
(Filed 1/31/07; passed House; passed Senate; signed into law by governor as Chapter 2007-447, 5/21/07) |
 
Tax, -
WA
HB 1850
Rep. Pederson
Would limit the sale or use of prescription information.
(Filed  1/30/07; did not pass by end of session 4/22/07) |  [News article 5/22/07]
Privacy, Mkt
WA
SB 5631
Would require licenses for wholesale distributors of prescription drugs; including every nonresident wholesale distributor if it ships into the state.
(Filed and sent to committee 1/26/07; did not pass by end of session) |
Whole
WA
SB 5917

Would require the disclosure of gifts from pharmaceutical manufacturers to person who can prescribe in the state.  Requires reporting of gifts, grants and gratitudes made by companies directly or indirectly to prescribers, purchasers or dispensers in the state.
(Filed and sent to committee 2/7/07; recommended do pass as substituted by committee; did not pass by end of session) |

Mkt
WA
SB 5973

Would establish a controlled substances monitoring program with real time tracking and reporting capabilities.
(Filed and sent to committee 2/9/07; recommended do pass as substituted by committee; did not pass by end of session) |

E
WV
HB 2007-enrolled
SB 65
Del. Thompson
Appropriates $501,800 for the operation of the WV Pharmaceutical Cost Management Council, charged with reducing costs of state-related and consumer drug purchases. 
(Filed 1/10/07; HB 2007 passed House 3/8/07; passed Senate; signed into law by governor with deletions 3/23/07)
D, M, Price
WV
HB 2173
Del. Eldridge
Would establish the Multiple Prescriptions Abuse Prevention Act.
(Filed 1/16/07; did not pass committee during regular session 3/7/07) |
E
WV
HB 2289
Del. Thompson
Would authorize the use of "E" or electronic prescribing, include permitting prescriber codes instead of handwritten signatures for substitutions.
(Filed 1/17/07; did not pass committee during regular session 3/7/07) |
E
WV
HB 2328
Del. Perdue
Would require licensure of pharmacy benefit managers; also require disclosures of any "incentive arrangement or programs such as rebates, discounts, disbursements, or any other similar financial program" with Rx manufacturers or wholesalers.
(Filed  1/19/07; did not pass committees during regular session 3/7/07)
PBM, Whole
WV
HB 2772
Del. Rodighiero
Would ensure the Public Employees Insurance Agency (PEIA) will continue prescription drug coverage for Medicare eligible retired employees; provides that if Medicare/Advantage Prescription Drug Plan should fail, the Public Employees Insurance Agency will take all Medicare eligible retired employees back into the existing Public Employees Insurance Agency plan or provide another plan of equal or better coverage.
(Filed 1/31/07; passed House 2/20/07; did not pass Senate during regular session 3/7/07)|
MMA
WV
HB 2695,
SB 305
Del. Brown
Would authorize the WV Pharmaceutical Cost Management Council to promulgate legislative rules relating to pharmaceutical advertising expense reporting, effective July 2008.
(Filed 1/26/07; did not pass committees during regular session 3/7/07)|
Mkt
WV
HB 3164
Del. Thompson
Would extend state programs to "lower prescription drug costs" and require manufacturers to disclose marketing and advertising strategies.  Would formalize a consortium of five or eight states, rather than 5 million covered individuals to negotiate bulk discounts. Would include "the expansion of primary care clinics offering pharmaceuticals under 340B Pricing Program.  Includes penalty of prison up to 10 years for Rx manufacturers stopping production of an unprofitable product if viewed as an attempt to fix prices.
(Filed 1/07; passed House 3/1/07; did not pass Senate committee 3/7/07; may be referred to special session 3/07)  (Related news article 3/7/07)
340B, Bulk, D, Mkt, Price
WV
HB 3057
Del. Perdue

Creates comprehensive health and social services to disabled and frail elderly persons, known as "PACE."  Includes prescription drug services within a managed care structure; consistent with federal laws, it exempts health providers participating in these programs from regulation as insurers.
(Filed 2/22/07; passed House; passed Senate; signed into law by governor 4/2/07) |

M, PDL
WV
HB 3190
Del. Morgan
SB 513
Sen. Prezioso
Would allow remote dispensing and delivery of prescription drugs with teleconferencing and clarifies "medical home."
(Filed and sent to committees 2/8/07; did not pass committee by deadline 3/7/07) |
 
E
WV
SB 69
Sen. Tomblin
Would authorize electronically transmitting prescription orders.
(Filed 1/12/07; passed Senate 2/5/07; amended and passed House 3/10/07; did not pass due to technical flaw 3/13/07) |
E
WV
SB 434
Sen. Hunter
Would prohibit dissemination of prescription information containing patient-identifiable and prescriber-identifiable data.  Violation of confidentiality would be "actionable as an unfair or deceptive practice."
(Filed 2/1/07; did not pass committee by deadline 3/7/07) |
Mkt, Privacy
WV
SB 621
Sen. Stollings
Would require the development of a standard and electronic format for preferred drug lists and establishes the length of time for which preferred drug lists are valid.
(Filed 2/15/07; passed Senate 2/28/07; did not pass committee by end of session 3/7/07) |
PDL, M
WV
SB 702
Sen. Prezioso
Would regulate out of state pharmaceutical sales.
(Filed 2/19/07; did not pass committee by end of session 3/7/07) |
Mail
WI
AB 12
Rep. Schneider
Would prohibit prescription drug manufacturers from "giving or offering anything of monetary value to any practitioner to encourage prescribing the manufacturer's drugs;" product samples would be excluded; includes a fine up to $10,000 per violation.
(Filed and sent to committee 1/12/07)
Mkt
WI
SJR 57
Would put to referendum  the question of continuing the program of prescription drug assistance for elderly persons (Senior Care) past December 30, 2009, as a permanent federal-state program.
(Filed and send to committee 8/2/07)
 S, MMA
WI
AB 16
Would require health insurance policies to cover orphan drugs.
(Filed and sent to committee 1/12/07)
Brand, Price
WI
AB 137

Would change eligibility and deductible amounts under the prescription drug assistance program for the elderly.
(Filed and sent to committee 3/5/07)

 Tax
WI
SB 39
Decreases funds for the Prescription Drug Assstance for the Elderly by $15,700,000 for fiscal year 2006-07, reflecting a part-year extension of federal matching funds.
(Filed; passed Senate and House; signed into law by governor as Act 5 of 2007, 3/11/07)
S
WI
SB 40

FY 2008-09 budget includes: 1) establishes a copayment of no more than $5 per prescription, and subject to the Badger Rx Gold program discounts. 2) Appropriates $61.8 million (incresaed fronm $54.2 million last year) for Prescription drug assistance for  Elderly; AIDS.   4) Recodifies the wholesale licensure and chain of pedigree for prescription drugs (in Sec. 3530e & g); 3) authorizes the Department of Agriculture, Trade and Consumer Protection to promulgate a rule necessary to authorize grants for programs to collect unwanted prescription drugs. (in Sec. 9103.)
5) Also establishes the structure for a comprehensive "Healthy Wisconsin" coverage reform, which features a standard health package including prescription drug copays at $5 generic, $15 brand name, and $40 for non-formulary drugs, but not more than the actual cost plus dispensing fee. Authorizes joining similar prescription drug bulk "arrangements or programs in other states to form a multistate purchasing group to negotiate with prescription drug manufacturers"
(Filed; passed Senate and House; signed into law by governor as Act 20 of 2007, 10/28/07)

Bulk, Copay, D, Price, Reuse, Whole
WY
HB 317
Rep. Millin
Would prohbit the substitiution of any anti-epileptic drug, prescribed for the treatment of seizures, without the written consent
8 of the prescribing physician.
(Filed 1/07; did not pass by end of regular session 3/17/07) |
Brand, Generic
WY
SB 61
Sen. Massie
Requires more extensive licensing of Rx distributors, including out-of-state distributors must be licensed within their own state; raises annual fee fro $100 to $1,000 and requires fingerprints and criminal history background check for applicants.  Also requires complete records of transactions and pedigrees for sales outside normal distribution. Effective date 7/1/07.
(Filed 1/24/07; passed Senate 2/5/07; passed Housesigned into law by governor as Chapter 211, 3/8/07) |
Safety, Whole

 

NCSL Pharmaceutical Resources:

 

Definitions and Notes:

[1] - Total U.S. Prescription drug spending from all sources, public, commercial and out-of-pocket total $213.7 billion for 2006, according to the report, "Health Spending Projections Through 2016: Modest Changes Obscure Part D’s Impact" by the Centers for Medicare and Medicaid Services, Office of te Actuary, published in Health Affairs, 2/21/07
> Federal Poverty Guidelines, often termed the federal poverty level (FPL), released January 24 for 2007.  The new guideline for an individual is $10,210, an increase from the 2006 figure of $9,800. For a married couple or 2-person household the figure is $13,690.  Higher figures apply for Alaska and Hawaii.
> MMA. Abbreviation for the federal Medicare Prescription Drug Improvement, and Modernization Act of 2003 (P.L.108-173), signed into law December 8, 2003.
> SPAP.  Abbreviation for State Pharmaceutical Assistance Program.  More than 30 individual states have authorized and/or operated such subsidy programs since 1975.  The MMA authorized and formalized federal-state coordination with existing programs.   

Methodology:  2007 legislation was identified via 50-state searches conducted in January-March, plus updates from NCSL's 2006 Prescription Drug State Legislation report and further individual state research using selected legislative web sites.  Similar bills may be combined into a single descriptive entry for the convenience of readers.  Bill descriptions are brief summaries written by NCSL.  Although in many cases descriptions include direct excerpts from official state text or descriptions, NCSL is responsible for the content in this report.   Bill status descriptions are simplified to reflect major steps only, such as filed, sent to committee, passed, did not pass, signed or vetoed. Sponsor includes the officially listed lead sponsor only; many bills have additional co-sponsors, with names normally listed on each bill.  Live web links are provided via bill numbers wherever possible – readers are encouraged to use these links to identify latest status, amendments, full list of committees and sponsors.  Future editions include "Powered by StateNet" features. Information provided in part by State Net, Inc..

Authors: This report was compiled by Karmen Hanson and Richard Cauchi, with editorial input from Martha King and Tina Thomas of the NCSL Health Program in Denver.

Future changes and editions:
This report was initially released March 27, 2007 as a “work in progress,” with new bills, major amendments, and major changes in status  updated at least twice a month during the calendar year.   Legislators and staff are welcome to submit substantive additions or changes to NCSL via email
For regular updates, view this report online at: www.ncsl.org/programs/health/drugbill07.htm |
For latest 2008 changes: www.ncsl.org/programs/health/drugbill08.htm

--------------------------------------------


Back to: Health Menu Page | Top of Page

Share this: 
NCSL Summit 2014
We are the nation's most respected bipartisan organization providing states support, ideas, connections and a strong voice on Capitol Hill.

NCSL Member Toolbox

Denver

7700 East First Place
Denver, CO 80230
Tel: 303-364-7700 | Fax: 303-364-7800

Washington

444 North Capitol Street, N.W., Suite 515
Washington, D.C. 20001
Tel: 202-624-5400 | Fax: 202-737-1069

Copyright 2014 by National Conference of State Legislatures